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Foreword 
The project “Systemic absorption of nanomaterials by oral exposure” was carried out during the 
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This report and the accompanying database (see appendix 7) are intended to provide a 
comprehensive evaluation of the knowledge base regarding the systemic absorption of 
nanomaterials by oral exposure based on the currently available scientific literature. 
These results regarding the oral exposure route for nanomaterials are part of the “Better control of 
nano” initiative conducted by the Danish EPA with the aim of further clarifying possible risks to 
consumers and the environment. 
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Main authors:  
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The project was financed by the National Budget Agreement 2012 on Better Control of 
Nanomaterials and their Safety (“Bedre styr på nano”).  
Danish EPA, September 2013 
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Dansk resumé 
I projektet "Systemisk absorption af nanomaterialer ved oral eksponering" er den udvalgte 
tilgængelige viden fra den videnskabelige litteratur om systemisk absorption af nanomaterialer efter 
oral eksponering vurderet. Projektet er en del af den danske Miljøstyrelses initiativ "Bedre kontrol 
af nano", der skal præcisere den mulige risiko for forbrugerne og miljøet ved udsættelse for 
nanomaterialer. 
Det overordnede formål med projektet var at indsamle og vurdere eksisterende viden på området. 
De mere specifikke mål var: 
1. At udføre en omfattende litteratursøgning og vurdering af pålideligheden og relevansen af 
studier med systemisk absorption af nanomaterialer ved oral eksponering (fase I). 
 
2. At evaluere de faktorer, der påvirker den systemiske absorption af nanomaterialer ved oral 
eksponering (fase II), herunder:  
 
a. En vurdering af de fysiske og kemiske egenskaber af nanomaterialer der er 
beskrevet i litteraturen, og som forventes at påvirke den systemiske absorption af 
nanomaterialer efter oral eksponering.  
 
b. En vurdering af hvilke testmetode(r) der bedst simulerer systemisk absorption af 
nanomaterialer ved oral eksponering under hensyntagen til kompleksiteten af 
fordøjelsessystemet og de faktorer, der kan have en indflydelse på den mulige 
systemiske absorption af nanomaterialer. 
 
3. At identificere manglende viden og forskningsbehov og anbefale, hvilke modeller og 
målemetoder der er mest velegnet til at simulere systemisk absorption af nanomaterialer ved 
oral eksponering hos mennesker. Endelig at anbefale relevante nanomaterialer som kandidater 
til eksperimentel testning i fremtiden (fase III).  
En trinvis litteratursøgningsprofil blev anvendt til at identificere relevante videnskabelige 
dokumenter, som blev screenet for deres relevans med hensyn til absorption (og dermed potentielle 
sundhedsskadelige effekter på mennesker via oral eksponering (lægemidler undtaget). I alt 64 
videnskabelige artikler blev udvalgt til nærmere vurdering af disses videnskabelige kvalitet baseret 
på de såkaldte Klimisch kriterier (om udførelsen af toksikologiske/biologiske eksperimenter), og 
detaljerne i karakteriseringen af nanopartiklerne blev noteret. Det endelige antal på 47 artikler med 
en Klimisch score på 1 eller 2 (nogle få artikler med en score på 3, blev også udvalgt baseret på en 
ekspert vurdering) blev udvalgt til yderligere vurdering. De typer af nanopartikler, der indgik i den 
valgte litteratur omfattede: kulstofnanorør, cerium dioxid, fullerener, guld, jernoxid, selen, silicium 
dioxid, sølv, titandioxid og zinkoxid. 
Evalueringen af fysiske og kemiske egenskaber, der forventes at påvirke absorptionen af 
nanopartikler viste, at få af disse parametre var undersøgt eller dokumenteret. For nogle 
nanomaterialer kunne en evaluering af de faktorer, der påvirker deres systemiske absorption efter 
oral eksponering ikke gives på grund af manglende data. Dette gælder for kulstofnanorør, cerium 
dioxid, fullerener, silicium dioxid og selen. Det blev påvist, at tarmens optagelse af jernoxid, guld og 
sølvnanopartikler var højere for de mindre partikelstørrelser end for de større partikler. 
8 Systemic Absorption of Nanomaterials by Oral Exposure 
 
Indflydelsen på absorptionshastigheden af polymerbelægninger på sølv nanopartikler blev 
undersøgt, men ingen klar tendens blev observeret. Opløseligheden af sølv og zinkoxid 
nanopartikler viste sig at være en uventet faktor i studiet af absorptionen på grund af de opløste, 
ioniske former af disse partikeltyper. For titandioxid nanopartikler var der ingen klare oplysninger 
om forholdet mellem størrelse og absorption, men der var tegn på, at agglomereringen af anatase 
krystalformen kunne forklare den lave absorption heraf og dermed indirekte forklare, hvorfor 
krystalformen rutil blev bedre absorberet end anataseformen. 
De metoder, der var mest lovende til vurdering af systemisk absorption af nanomaterialer blev 
evalueret. Metoder baseret på in vitro test eksisterer og er i øjeblikket under udvikling. Der er 
imidlertid behov for yderligere forfining før disse metoder kan anvendes til vurdering af absorption 
af nanopartikler efter oral eksponering. Den mest lovende modeltype bør omfatte et syntetisk 
system under brug af fysiologisk relevante betingelser (enzymer, pH, salte og temperatur) alene 
eller bør anvendes i kombination med en in vitro absorptionsmodel baseret på f.eks. humant 
tarmepitel eller Caco-2celler. Sølv og siliciumdioxid nanopartikler er blevet testet under sådanne 
syntetiske betingelser, og tilstedeværelsen af nanopartikulært materiale i kunstige tarmsaft uden 
eller med tilstedeværelsen af en fødevare matrix blev demonstreret. En in vitro-model baseret på 
humant follikelstimulerende epithel blev udviklet, men der var en tendens til at overvurdere 
transporten af nanopartikler over denne cellebarriere. Dette viste, at resultaterne fra in vitro 
modeller på absorption af nanopartikler bør fortolkes med forsigtighed. 
Det sidste kapitel i rapporten er afsat til identifikation af huller i vores viden og til anbefalinger 
vedrørende fremtidig testning af nanomaterialer. Generelt er meget få robuste og validerede in vivo 
absorptionsstudier blevet identificeret. Den kombinerede Klimisch og nanomateriale-
karakteriseringsscore tyder på, at især fremskridtet i arbejdet med karakterisering af nanopartikler 
er begrænset. Dette er sandsynligvis forbundet med tekniske og videnskabelige udfordringer 
forbundet med påvisning af nanopartikler i biologiske matricer. Detaljerede undersøgelser af 
indflydelsen af fysisk-kemiske egenskaber på absorption er nødvendige, og kunne i første omgang 
udføres in vitro for at spare tid samt minimere anvendelsen af forsøgsdyr. Når flere data er blevet 
tilgængelige, kan det blive muligt at overføre viden eller at udvikle "in situ" modeller for absorption 
af "næsten ens" nanomaterialer.  
Analytiske metoder til karakterisering af nanomaterialer er under intens udvikling og omfatter våd-
kemiske teknikker, der ofte er baseret på atomspektroskopi og på billeddiagnostiske metoder, f.eks 
elektronmikroskopi. Der er behov for yderligere udvikling af følsomme og pålidelige metoder til 
påvisning og karakterisering in situ og til kvantificering af masse og partikelantal især i 
fødevarer/foder og i væv/celler indsamlet fra in vivo eller in vitro modeller. Fra sådanne 
undersøgelser, er det vigtigt at indsamle oplysninger om, hvorvidt stofferne optages som partikler, 
ioner eller en kombination af begge. I projekter, hvor forskerne har adgang til en moderne 
"analytisk værktøjskasse", kan den selektive påvisning af ioner vs partikler af et givet nanomateriale 
opnås på en række måder. I almindelighed kan metoder, som bygger på kombinationen af en 
separationsteknik og en selektiv detektor (ICP-MS) være en måde at opnå mere relevante 
karakteriseringsoplysninger i fremtidige projekter. 
Baseret på den nærværende vurdering af nanomaterialer, er materialer med et højt oralt 
eksponeringsniveau de mest relevante kandidater til fremtidige projekter vedrørende systemisk 
absorption af nanomaterialer efter oral eksponering. Disse materialer omfatter sølv, siliciumdioxid 
(E 551), titandioxid (E 171) og zinkoxid. 
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Summary 
In the project “Systemic absorption of nanomaterials by oral exposure” the available knowledge 
selected from the scientific literature on systemic absorption of nanomaterials following oral 
exposure is evaluated. The project is part of the “Better control of nano” initiative by the Danish 
EPA aiming at clarifying possible risks to consumers and the environment upon exposure to 
nanomaterials. 
The overall aim of the project was to gather and evaluate existing knowledge in the area. More 
specifically the objectives were: 
1. To perform an extensive literature search and assessment of the reliability and relevance of 
studies involving systemic absorption of nanomaterials by oral exposure (Phase I).  
2. To evaluate the factors influencing systemic absorption of nanomaterials by oral exposure 
(Phase II) including: 
a. An evaluation of the physical and chemical properties of nanomaterials described in 
the literature, which are expected to affect the systemic absorption of nanomaterials 
following oral exposure.  
b. An evaluation of which test method(s) would most closely simulate systemic 
absorption of nanomaterials by oral exposure taking into account the complexity of 
the digestive system and the factors that may have an influence on the possible 
systemic absorption of nanomaterials. 
3. To identify knowledge gaps and research needs and to recommend which models and 
measurement methods are most suited for simulating systemic absorption of nanomaterials by 
oral exposure in humans. Finally, relevant nanomaterials should be recommended as 
candidates for experimental testing in the future (Phase III).  
A multi-stage literature search profile was applied to identify relevant scientific papers, which were 
screened for their relevance regarding potential adverse effects to humans of nanomaterials via oral 
exposure (pharmaceutica excluded). A total of 64 scientific papers were selected for further 
evaluation of scientific quality based on the so-called Klimisch criteria (about the conduction of 
toxicological/biological experiments) and the detail of nanoparticles characterisation was listed. A 
final number of 47 papers with a Klimisch score of at least 2 (a few papers with a score of 3 were 
also included based on expert judgement) were considered for further evaluation. The types of 
nanoparticles that were included in the selected literature included: carbon nanotubes, cerium 
dioxide, fullerenes, gold, iron oxide, selenium, silicium dioxide, silver, titanium dioxide and zinc 
oxide. 
The evaluation of the physical and chemical properties that were expected to influence absorption 
of nanoparticles showed that generally few of these parameters were investigated or documented. 
For some substances an evaluation of factors influencing their systemic absorption following oral 
exposure cannot be given due to lack of data. This includes carbon nanotubes, cerium dioxide, 
fullerenes, silicium dioxide and selenium. It was demonstrated that the intestinal uptake of iron 
oxide, gold and silver nanoparticles was higher for smaller the for larger particle sizes. The 
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influence on absorption rate of polymeric coatings of silver nanoparticles was investigated, but no 
clear trend was observed. The solubility of silver and zinc oxide nanoparticles proved to be an 
unexpected factor in the absorption of the dissolved, ionic forms of these particle types. For 
titanium dioxide nanoparticles there was no clear information on relationship between size and 
absorption, but there was some indication that agglomeration of the anatase crystal form could 
explain the low absorption of this form and indirectly explain why the rutile form of TiO2 was better 
absorbed than the anatase form.  
The methods that were most promising for assessment of systemic absorption of nanomaterials 
were evaluated. Methods based on in vitro testing indeed exist and are currently under 
development. Further refinement is however needed before they may be applied to assessment of 
hazard or to absorption of nanoparticles after oral exposure. The most promising type of model 
should include a synthetic set-up using physiologically relevant conditions (enzymes, pH, salts and 
temperature) alone or should be used in combination with an in vitro absorption model based on 
e.g. human intestinal epithelium or Caco-2 cells. Silver and silicium dioxide nanoparticles were 
tested under synthetic conditions, and the existence of nanoparticulate matter of these substances 
in artificial intestinal juice without or with the presence of a food matrix, respectively, was 
demonstrated. An in vitro model based on human follicle epithelium was developed but tended to 
overestimate the transport of nanoparticles across the cell barrier. This demonstrated that results 
from in vitro models on absorption of nanoparticles should be interpreted with caution.  
The final chapter of the report is devoted to the identification of knowledge gaps and to 
recommendations for future testing of nanomaterials. Generally, very few robust and validated in 
vivo absorption studies have been identified. The combined Klimisch and nanomaterial 
characterisation scores suggest that especially the advancement of the characterisation work is 
limited. This is likely because of the technical and scientific challenges associated with detection of 
nanomaterials in biological matrices. Detailed studies on the influence of physical chemical 
characteristics on absorption are needed and could be performed initially in the in vitro models in 
order to save time and animals’ lives. When more data has been created, it may be possible to “read 
across” or to develop “in situ” models for absorption of “nearly similar” nanomaterials.  
Analytical methods for nanomaterial characterisation are under intense development and comprise 
wet chemical techniques, often based on atomic spectroscopy, and on imaging methods, e.g. 
electron microscopy techniques. There is a need for further development of sensitive and reliable 
methods for the detection and characterization in situ and for quantification of mass and number of 
NPs especially in food/feed and tissues collected from in vivo or in vitro study models. From such 
studies it is important to collect information on whether substances are absorbed as particles, ions 
or a combination of both. In research projects, where the investigators have access to a modern 
“analytical toolbox”, the selective detection of ions vs. NPs of a given nanomaterial can be achieved 
in a number of ways. In general, methodologies which rely on a combination of a size separation 
technique with a selective detector (ICP-MS) may be a way to achieve more relevant 
characterisation information in future projects.  
Based on the present evaluation of different nanomaterials, substances with a high exposure level 
via the oral route are the likely candidates for future projects on systemic absorption of 
nanomaterials following oral exposure. Such substances include silver, silicium dioxide (E 551), 
titanium dioxide (E 171) and zinc oxide.  
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1. Introduction 
1.1 Danish initiative for “Better control of nano” 
The Danish government and the Red-Green Alliance (a.k.a. Enhedslisten) have signed an 
agreement called “Bedre styr på nano” (“Better control of nano”) for four years (2012-2015) that 
focuses on the use of nanomaterials in products on the Danish market and their consequences on 
consumers and the environment. The Danish Environmental Protection Agency (EPA) has initiated 
a series of projects with the aim of further clarifying possible risks to consumers and the 
environment. The current project and accompanying literature database is part of this series. 
1.2 Project outline 
As part of this series of projects on key issues regarding nanomaterials in Denmark, such as 
occurrence, extent of consumer and environmental exposure and assessment of potential risk, the 
Danish EPA commissioned the present literature study on the systemic absorption of nanomaterials 
by oral exposure. The overall aim of the project was to gather and evaluate the existing knowledge 
in the area and assess the need to generate new knowledge, as well as to develop recommendations 
for the most suitable models of systemic absorption by oral exposure, measurement methods and 
suggest relevant candidate nanomaterials for experimental testing in the future. 
1.3 Background 
Nanomaterials have attracted strong interest in various ﬁelds of industry and research, since their 
small size offers new features and enhanced reactivity in comparison to larger particles of the same 
chemical composition. Their use can already be found in a broad ﬁeld of applications, for instance 
as pigments and resins, as UV-filters in cosmetics, in drug delivery systems, or for applications in 
medical diagnostics. The food industry is starting to use various nanoparticles as food additives or 
to improve food packaging in an attempt to optimize their products. While microparticles, such as 
titanium dioxide (TiO2) or silicium dioxide (SiO2) already have a long standing use as food 
additives, for example as whiteners (e.g. TiO2), enhancers of viscosity, and ﬂuxing agents (e.g. 
SiO2) (Chaudhry et al. 2008); (Schmid and Riediker 2008) as cited in (Gerloff et al. 2009), 
nanoparticles (NPs) may also be used as components of novel food packaging materials in the 
future due to their gas barrier properties, gas exchange and their antimicrobial properties (e.g. ZnO 
and MgO). More advanced approaches in the food industry include nanoparticle-based sensors to 
monitor food edibility or nano-encapsulation applications to improve nutrient stability and targeted 
delivery (Taylor et al. 2005); (Asuri et al. 2007); (Kaittanis et al. 2007) as cited in (Gerloff et al. 
2009).  
The human body may be intentionally or unintentionally exposed to nanomaterials via several 
possible routes, including oral ingestion, inhalation, intravenous injection, and dermal absorption. 
The behaviour of nanomaterials within the gastro-intestinal tract have been poorly investigated and 
therefore the fate and effects of nanoparticles ingested via food, water or swallowed following cilia-
transport from the lungs, remains essentially unknown.  
To date, almost all in vivo studies on nanomaterials have focused on the evaluation of acute toxicity 
and repeated-dose toxicity via different exposure routes. Only few studies have investigated 
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nanomaterials in animals after oral administration. Such studies include pharmacokinetic studies 
on their absorption, distribution, metabolism, and excretion (ADME) patterns at the systemic level. 
Pharmacokinetic studies on nanomaterials is of paramount importance in the context of 
understanding the amount absorbed via the gastro-intestinal tract and how it enters the systemic 
circulation as well as the kinetic profile of its clearance by the excretory systems. This will provide 
clues for the underlying debate on the safety of nanomaterials. In recognising the paucity of 
knowledge on absorption of nanomaterials in humans after oral exposure the Danish 
Environmental Protection Agency (DEPA) commissioned this project to review the available, 
relevant literature on oral absorption of nanomaterials in vivo and in vitro. 
Oral exposure to nanomaterials mainly occurs via ingestion of food e.g. as food additives or due to 
migration from food contact materials (FCM). Risk assessments of such substances are evaluated by 
the European Food Safety Authority (EFSA). EFSA has published two Scientific Opinions on 
nanomaterials in food and feed. In these opinions the term “engineered nanomaterial (ENM)” 
refers to a nanomaterial produced either intentionally or unintentionally (due to the production 
process) to be used in the food and feed area.  
In the present report we will use the term nanoparticles (NPs) when we are talking about specific 
particles (e.g. Ag-NPs) and nanomaterials (which includes NPs) as a broader and more general term 
instead of ENM, because it is used in most of the reviewed articles. Only in this chapter citing the 
EFSAs guidance document we will use ENM. 
The first Scientific Opinion: “The potential risks arising from nanoscience and nanotechnology on 
food and feed safety EFSA (EFSA 2009)” is generic in nature and is not in itself a risk assessment of 
nanotechnologies used for food and feed. 
In the second Scientific Opinion: “Guidance on the risk assessment of the application of 
nanoscience and nanotechnology on food and feed chain” (EFSA 2011), which is a follow up of the 
first report from 2009, guidance is provided on: (i) the physico-chemical characterisation 
requirements of engineered nanomaterials used e.g. as food additives, enzymes, flavourings, food 
contact materials, novel foods, feed additives and pesticides and; (ii) testing approaches to identify 
and characterise hazards arising from nano-specific properties which, in general, should include 
information from in vitro genotoxicity studies, studies on absorption, distribution, metabolism and 
excretion, and studies on repeated- dose 90-day oral toxicity studies in rodents. The guidance 
allows for reduced information to be provided when no exposure to the engineered nanomaterial is 
verified by data indicating no migration from food contact materials or when complete 
degradation/dissolution is demonstrated with no absorption of engineered nanomaterials as such.  
In EFSAs “Guidance on the risk assessment of the application of nanoscience and nanotechnologies 
in the food and feed chain” (2011) it is emphasized that adequate physical/chemical 
characterisation of nanomaterialss is essential for risk assessment of the nanomaterialss. The 
characterization should ideally be determined in five stages, i.e. as manufactured (pristine state), as 
delivered for use in food/feed products, as present in the food/feed matrix, as used in toxicity 
testing, and as present in biological fluids and tissues.  
The ADME of a nanomaterial are likely to be influenced both by the chemical composition of the 
ENM as well as its physico-chemical properties (e.g. size, shape, solubility, surface charge and 
surface reactivity). 
When it can be demonstrated that an ENM completely dissolves/degrades in then gastro-intestinal 
tract without absorption of the ENM, the hazard identification and hazard characterisation can rely 
on data for the non-nanoform substance (if available).  
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When information on a non-nanoform of the same substance is available and where some or all of 
the ENM persists in the food/feed matrix and in gastro-intestinal fluids, a testing approach is 
recommended, which is based on comparing information on ADME, toxicity and genotoxicity of the 
non-nanoform with ADME, repeated-dose 90-day oral toxicity study and genotoxicity information 
of the ENM. When information on a non-nanoform is not available and where some or all of the 
ENM persists in the food/feed matrix and in gastro-intestinal fluids, the approach for toxicity tests 
on the ENM should follow the relevant EFSA guidance for the intended use with the modifications 
in the present ENM Guidance to take into account the nano-specific properties. 
At present very limited information is available that EFSAs theoretical approach on risk assessment 
of nanomaterials in food has been used in practice. One study has been identified in the open 
literature where EFSAs approach has been used for risk assessment of nanosized silicium dioxide in 
food (Dekkers et al. 2012). The result of this exercise as regards the intestinal absorption of 
nanosized silicium dioxide is shortly described in chapter 3.12.  
1.4 Current understanding and models of systemic absorption of 
nanoparticles by oral exposure 
The mechanism of translocation (absorption) of nanoparticles over the gastro-intestinal (GI) wall 
appears to be complex and is poorly understood. For the entire GI tract, composed of the oral 
cavity, the esophagus, the stomach and the small and large intestines, mucus represents an efficient 
acellular barrier. The pH varies in the different compartments of the GI tract. The pH of the mucus 
in the oral cavity is estimated to be around pH 6.6. The gastric mucus shows a wide pH range from 1 
to 2 (luminal) to ∼7 (epithelial surface) (Frölich and Roblegg 2012) and in the intestines the pH is 
around 8 (Peters et al. 2012).  
The epithelium generally represents the highest resistance against the passage of chemical 
compounds and NMs. The intestinal epithelium consists of a monolayer of predominantly 
enterocytes, and in certain regions specialized cells called M-cells (Microfold cells). M-cells are 
preferentially located in the epithelium overlying the Peyer’s Patches (located in the lowest portion 
of the small intestine, the ileum, in humans) which is also called Follicle Associated Epithelium 
(FAE). M cells differ from normal enterocytes in that they lack microvilli on their apical surface, but 
instead possess broader microfolds that give the cell its name. They transport organisms and 
particles from the gut lumen to immune cells across the epithelial barrier via endocytosis or 
phagocytosis (transcytosis), and deliver foreign substances to the underlying tissues (mucosa 
lymphoid) to induce immune responses. However M-cells, are also a potential portal for systemic 
entry of NPs. 
Translocation of NPs through the epithelium is a multistep process, involving diffusion through the 
mucus lining of the gut wall, contact with enterocytes and particularly the M-cells, and finally 
uptake via either paracellular (passage through the cells) or transcellular (passage between the 
cells) transport (Bouwmeester et al. 2011).   
Translocation of NPs through the epithelium depends on their physic-chemical properties such as 
size, surface charge, lipophilicity/hydrophilicity, presence/absence of a ligand (Bouwmeester et al. 
2011).   
Since the plasma membrane of the cells forming the epithelial barrier is lipophilic, lipophilic 
substances are taken up passively by the transcellular route whereas hydrophilic substances use the 
paracellular route. The penetration area of the paracellular route is extremely small compared to 
the transcellular route and restricted to polar substances below 1000 Dalton. Paracellular transport 
of chemicals is only passive and NPs are not expected to be able to use the paracellular route, 
because they are considerably larger than 1000 Dalton.  
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Several in vitro models for translocation of chemicals over the intestinal epithelium have been 
developed. Generally monolayers of Caco-2 cells are preferred as models (Bouwmeester et al. 2011). 
However, more recently a more sophisticated in vitro model of human Follicle Associated 
Epithelium (FAE) has been developed by des Rieux and co-workers. This model was developed to 
study NP transport mechanisms by M-cells (des Rieux et al. 2007). The model is based on a co-
culture of inverted transwell inserts of Caco-2 cells and human Raij B lymphocytes. The set-up of 
the system allows a close contact between the two cell types to trigger the conversion of Caco-2 cells 
into M-cells. The authors showed an M-cell conversion rate of 15-30% by means of scanning 
electron microscopy. This in vitro model seems to have a great potential in the study of both 
translocation and toxicity of nanomaterials.  
1.5 Aim of the project 
The aims of the project are: 
Phase I: To perform an extensive literature search and assessment of the reliability and relevance of 
studies involving systemic absorption of nanomaterials by oral exposure.  
Phase II: To evaluate the factors influencing systemic absorption of nanomaterials by oral exposure 
including:  
1) An evaluation of the physical and chemical properties of nanomaterials, described in 
the literature, which are expected to affect the systemic absorption of nanomaterials 
by oral exposure such as size, shape, electrical charge, surface coating, leaching of 
chemicals from nanomaterials, agglomeration etc.  
 
2)  An evaluation of which test method(s) would most closely simulate systemic 
absorption of nanomaterials by oral exposure taking into account the complexity of 
the digestive system and the factors that may have an influence on the possible 
systemic absorption of nanomaterials 
Phase III: To identify knowledge gaps and research needs and to recommend which models and 
measurement methods are most suited for simulating systemic absorption of nanomaterials by oral 
exposure. Finally, relevant nanomaterials should be recommended as candidates for experimental 
testing in the future.  
These assessments will be based on the currently available scientific literature in this area including 
relevant in vivo and in vitro data on oral exposure.   
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2. Phase I: Establishing a 
database based on a survey 
of relevant literature  
2.1 Literature search 
2.1.1 Description of the search strategy 
The literature search was performed by using SciFinder encompassing Medline and ChemAbs (for 
further explanation see Appendix 1, introduction). 
Step 1: 
In our search strategy we used a stepwise approach starting with the search terms listed in table 1. 
 
FIGURE 1 KEY SEARCH TERMS USED IN STEP 1  
This figure shows the seven search terms describing various nanomaterials, which were combined 
with a total of 23 keywords deemed relevant for the purpose of identifying relevant papers 
concerning the systemic absorption of nanomaterials by oral exposure. 
Nanomaterials Keywords 
Nano Oral, Gavage, Food, Absorption, 
Gastrointestinal, GI tract, Digestive tract , 
Gastric, Saliva, Intestine, Stomach, 
Duodenum, Jejunum, Ileum, Peyer’s patch, 
Cecum, Colon, Feces, Epithelial barrier, Cell 
line, Caco-2, Enterocyte, Consumer products. 
Microparticle 
Particle 
Particulate 
Colloid 
Quantum dot 
Fullerene 
The results of the searches are shown in Appendix 2. 
It was agreed at this step to ignore patents as it was foreseen that most of the patents would relate 
to medicine science and were thus considered of limited relevance for this project aimed at 
consumer protection.  
Step 2: 
The number of hits found in step 1 was too many to continue the process and a step was made to 
identify commonly used terms, not relevant for the purpose of this project, starting with “nano-“ 
and to see if exclusion of these could diminish the number of hits. The terms were: 
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Nanogram, nanosecond and nanomet* (meter, metre etc).  
The results of the searches are shown in Appendix 3. 
It was concluded to exclude these terms in all following searches in order to reach a manageable 
number of relevant papers to be considered in this first part of the project.  
Step 3: 
The result obtained in step 2 indicated that an additional step was needed to refine the search 
further. Based on decisions made by the chemistry and toxicology experts the following 
combinations were used: The number of hits using the search term “nano” were reduced by refining 
the search. “Nano” hits also containing the word: “oral”, were identified and all reviews and patents 
were excluded 
The search was then further refined by identifying the previous hits containing the words “uptake” 
followed by “absorption”. From this result, hits containing the following terms were excluded: 
“nanogram”, “dermal”, “inhalation”. Thereafter all duplicates of papers were removed. This search 
was performed 25 January 2013. 
Based on this result, the search was further refined by excluding terms: [language: Chinese], drug, 
insulin, nanomolar, nanoemulsion. This search was performed 30 January 2013.The results of the 
searches are shown in Appendix 4. 
Step 4:  
In step 4 the searches exclude the following terms to further reduce the vast amount of hits:  
Drug, insulin, cancer, delivery, nanomolar, nanoemulsion and nanogram.  
This exclusion was based on expert judgement and found to be acceptable because with these search 
terms, a lot of papers were identified with no relevance for the project. Typically they were primarily 
related to health effect and drug delivery systems (e.g. for treatment of cancer). There could be a 
theoretical risk that cancer studies describing absorption would be excluded. However, it is not 
expected that oral long term studies have been performed on nanomaterials. Papers in Chinese as 
well as patent information were also excluded.  
This search with “nano” as search topic and the above mentioned exclusion resulted in 836,397 hits 
(search 207, see Appendix 5.) 
These “hits” were used for the following search by combining search 207 with each of the following 
search terms (a-j) 
a) Oral    (search 208) 
b) Oral + absorption   (search 209)  
c) Oral + uptake   (search 210) 
d) Gavage    (search 211) 
e) Gavage - oral   (search 212) 
f) Gastro-intestinal   (search 215) 
g) Gastro-intestinal - oral  (search 216) 
h) Gastro-intestinal - oral - uptake (search 217) 
i) Caco-2     (search218) 
j) Caco-2 + uptake   (search 219) 
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The results of the searches 209 (44 hits), 210 (26 hits), 212 (15 hits), 217 (401 hits) and 219 (33 
hits), in total 519 hits are shown in Appendix 6. The abstracts from these searches were saved as 
.pdf files and .ris files (for later import to the Reference Manager database). 
Step 5: 
In Step 5 a chemist and a toxicologist evaluated the 519 abstracts for relevance in relation to the 
project. The inclusion was based on “expert judgement”. As a default, the criteria used for inclusion 
were: 
• Only papers describing oral absorption (i.v. and i.p. injection were not included) 
• Only papers with relevance for humans i.e. animal studies in mammals/rodents. Studies in 
snails, fish or insects were not included 
• Only studies on nanomaterials used in consumer products or food. Drugs or drug delivery 
systems were not included 
Possible relevant abstracts were included in a Reference Manager database and the original papers 
downloaded as pdf files. In total, 76 original papers were included in the database.  
After a critical review of the 76 papers 64 were found relevant for further evaluation (table 1) and 
were evaluated in a two-step procedure described by Card et al. 2010 (Card and Magnuson 2010). 
With a few exceptions only papers with a Klimisch score of 1 or 2 (Klimisch et al. 1997) were 
described and evaluated in phase II of the project. 
Figure 2 summarises phase I of the project “Systemic absorption of nanomaterials by oral 
exposure”. It concerns the identification of relevant papers in a literature survey performed in 2013 
and described in step 1 to step 5, followed by assessment of relevance and reliability by the use of 
the Klimisch criteria (Klimisch et al. 1997) and nanomaterial characterisation (Card and Magnuson 
2010). These papers were further scrutinised in phase II of the project and factors influencing the 
systemic absorption of nanomaterials after oral exposure were identified. In phase III data gaps and 
future research needs were identified and discussed. 
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FIGURE 2 OVERVIEW OF THE LITERATURE SEARCH AND VALIDATION STRATEGY 
Search term ”nano” resulted in approx 1.2 million hits 
Terms excluded: drug, insulin, cancer, delivery, nanomolar, 
nanoemulsion, nanogram, [Chinese language] and patent 
 Approx 830.000 hits 
(S-207) 
 + ”oral”  + ”gavage”  + ”gastrointestinal”  + ”caco-2” 
685 hits  
(S-208) 
 43 hits  
(S-211) 
447 hits 
(S-215) 
- ”oral” 
403 hits  
(S-216) 
+ ”absorption” + ”uptake” 
26 hits 
(S-210) 
 44 hits  
 (S-209) 
- ”oral” 
15 hits  
(S-212) 
- ”uptake” 
401 hits  
(S-217) 
486 hits  
(S-218) 
+ ”uptake” 
33 hits 
(S-219) 
519 hits 
Expert judgement of abstracts to select original 
papers included in Refman database 
76 hits 
64 hits (See table 1, result of final search) 
Expert judgement of original papers 
Phase II 
Assessment of relevance and reliability by Klimisch 
criteria and level of nanomaterial characterisation 
according to Card and Magnuson (2010) 
Phase I 
38 in vivo studies, 
30 are relevant 
and reliable, see 
table 2 
21 in vitro studies, 
12 are relevant and 
reliable, see table 3 
6 ”synthetic” studies,  
3 are relevant and 
reliable, not tabulated 
The papers considered relevant and reliable are 
reviewed in phase II  
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2.1.2 Result of the search 
The types of nanomaterials identified, using the described search strategy were:   
• Metal oxides: zinc oxide, titanium dioxide, cerium dioxide, silicium dioxide, magnesium 
oxide, iron oxide 
• Metals and metalloids: silver, gold, selenium 
• Carbon based: carbon nanotubes, fullerenes 
• Quantum dots  
• Polymers (PMMA, PLGA, polystyrene)  
• Polysaccharides 
• Metallo-proteins: ferritin  
In the Reference Manager database the inserted user defined keywords by type of particle and study 
(i.e. in vivo, in vitro and synthetic) were used to identify original papers describing studies that are 
either “in vivo”, “in vitro” or “synthetic” and also which naniomaterial type was studied. In this 
context synthetic means a version of an in vitro study in which synthetic experimental conditions 
have been used aiming at mimicking a set of natural conditions. 
This information can be seen as extra columns in the reference list display (see screenshot below).  
FIGURE 3 SCREENSHOT FROM REFERENCE MANAGER DATABASE 
 
 
Using the search term “NP type” (= user Def1) in the Reference Manager database listed abstracts 
corresponding to the different nanomaterials, which were sub-divided into “in vivo”, “in vitro” and 
“synthetic”. During review of these abstract lists, 9 papers were regarded as irrelevant for this 
project or not of sufficient quality. Three papers on quantum dots were also not included as this 
nanomaterial is not considered relevant for consumer products. This resulted in a total of 64 
original papers Table 1 below shows the result of the search with the number of papers for the 
different type of nanomaterials distributed in “in vivo”, “in vitro” and “synthetic” investigations. 
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 TABLE 1 RESULT OF THE FINAL SEARCH WITH THE NUMBER OF PAPERS FOR THE DIFFERENT TYPE OF 
NANOMATERIALS SUB-DIVIDED BY "IN VIVO", "IN VITRO" AND "SYNTHETIC" INVESTIGATIONS. 
Nanomaterials In vivo In vitro Synthetic Total 
number of 
original 
papers  
Carbon nanotubes 6 4 1 10 
Cerium dioxide 1 1 0 2 
Fullerene 1 0 0 1 
Gold 2 0 0 2 
Iron, Iron oxide, 
Iron hydroxide 
and ferritin  
2 3 0 5 
Polymers (Latex, 
PLGA, PMMA, 
polystyrene, 
polysaccharide) 
4 7 0 11 
Selenium 0 1 0 1 
Silicium dioxide, 
Silicium 
aluminium 
hydroxide 
0 0 2 2 
Silver 11 3 3 17 
Titanium dioxide, 
silicium dioxide or 
zinc oxide 
4 1 0 5 
Zinc oxide 7 0 0 7 
 38 211 6 64 
1 One of the in vitro studies for carbon nanotubes also contains in vivo data, and is consequently 
reported twice.  
2.1.3 Evaluation of the original papers using Klimisch criteria and nanomaterial 
characterisation 
All the papers in the Reference Manager database have been downloaded from the DTU or KU 
library. The papers were distributed between the participants in the project and evaluated for 
relevance and reliability using a two-step procedure described in Card (Card and Magnuson 2010 
(Card and Magnuson 2010) and Magnuson et al. 2011 (Magnuson et al. 2011). The two-step 
procedure consisted of an initial “study score” using the ToxRTool (ToxRTool 2013) with Klimisch 
criteria (Klimisch et al. 1997) followed by an assessment of the level of nanomaterial 
characterisation.  
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For this purpose a spreadsheet was made for each nanomaterial and includes in each file evaluation 
of “in vivo”, “in vitro” and “synthetic” studies (see chapter 2.2.2). In principle only studies with a 
Klimisch score of 1 or 2 were regarded valid for evaluation and were further assessed for 
nanomaterial characterisation. However, a few studies with a Klimisch score of 3 were also 
considered of relevance for this project. 
These spreadsheets are submitted together with this report.  
Those of the in vivo and in vitro studies listed in table 1 that were considered relevant and reliable 
based on this two-step procedure are tabulated in tables 2 and 3 here below. Table 2 list 31 papers 
covering in vivo studies and table 3 lists 10 papers covering in vitro studies. The “synthetic” studies 
are not tabulated, but of the six papers identified three were considered to be of sufficient quality. 
These are one for nanotubes (Wang et al. 2011) and two papers for silver (Roger et al. 2012 and 
Walczak et al. 2012). 
These papers are used in phase II of the project. 
TABLE 2 EVALUATION OF IN VIVO STUDIES 
Nanomaterials 
studied in vivo 
Publication Species  
studied 
Oral 
dosing 
route1 
Nanostudy 
score 
Carbon 
nanotubes  
Lim et al. 2011a Rat Gavage K1-N0 
Carbon 
nanotubes  
Lim et al. 2011b Rat Gavage K1-N0 
Carbon 
nanotubes  
Matsumoto et al. 2012 Rat Gavage K1-N1 
Carbon 
nanotubes 
Awasti et al. 2013 Mice Gavage K2-N0 
Carbon 
nanotubes 
Sachar and Saxena 
2011 
Mice Gavage K1/3-N0 
Cerium dioxide Park et al. 2009 Rat  Oral K1-N1 
Fullerene Yamago et al. 1995 Rat Oral K2-N3 
Fullerene Yamashita et al. 2013 Mice Oral K1-N2 
Gold Zhang et al. 2010 Mice Oral K1-N3 
Gold Jumagazieva et al. 
2011 
Rat Oral K2/3-N1 
Iron oxide Singh et al. 2013 Rat Gavage K1-N5 
Iron oxide McCullough et al. 1995 Rat Oral K2-N0 
Silver Loeschner et al. 2011 Rat Gavage K1-N5 
Silver Sardari et al. 2012 Rat Gavage K1-N1 
Silver Van der Zande et al. 
2012 
Rat Oral K1-N3 
Silver Kim et al. 2009 Rat Oral K2/3-N0 
Silver Kim et al. 2010 Rat Oral K1-N1 
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Silver Park et al. 2010 Mice Oral K1-N1 
Silver Shahare et al. 2013 Mice Oral K1-N3 
Silver Hadrup et al. 2012a2 Rat Gavage K1-N4 
Silver Hadrup et al. 2012b2 Rat Gavage K1-N4 
Silver Kim et al. 20082 Rat Oral K1/3-N0 
Titanium dioxide Wang et al. 2012 Rat Gavage K1-N10 
Titanium dioxide Onischenko et al. 2012 Rat Gavage K3-N1 
Titanium dioxide Wang et al. 2007 Mice Oral K1-N1 
Titanium dioxide  Jani et al. 1994 Rat Gavage K3-N3 
Zinc oxide Baek et al. 2012 Rat Gavage K1-N4 
Zinc oxide Li et al. 2012 Mice i.p. 
injection 
K1-N4 
Zinc oxide Wang et al. 2008 Mice Gavage K1-N5 
Zinc oxide Lee et al. 2012a Rat Gavage K2/3-N2 
Zinc oxide Lee et al. 2012b Mice Oral K1/3-N2 
1 When it is not clear whether the dosing route was via gavage or dietary the term “oral” is used. 
2 These articles were not deemed relevant for oral absorption when reviewed in phase II. 
TABLE 3 EVALUATION OF IN VITRO STUDIES 
Nanomaterials 
studied  
in vitro 
Publication Cell type Nanostudy 
score 
Carbon nanotubes  Jos et al. 2009 Caco2 K1/3-N0 
Carbon nanotubes Szendi and Varga 
2008 
Human lymphocytes  
S. typhimurium 
K1/3-N0 
Carbon nanotubes Cicchetti et al. 2011 Human gingival 
fibroblasts 
K1/3-N0 
Carbon nanotubes Sachar and Saxena 
2011 
Erythrocytes K1/3-N0 
Cerium dioxide Gaiser et al. 2009 C3A human 
hepatocyte 
Caco2 
K1-N4 
Selenium Wang, Fu 2012 Caco2 K1-N2 
Silicium dioxide Peters et al. 2012 Model of human 
digestion 
 
Silver Gaiser et al. 2009 C3A human 
hepatocyte 
Caco2 
K1-N3 
Silver Bouwmeester et al. 
2011 
Caco2 cells 
and human Raij B 
lymphocytes 
K3-N6 
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Titanium dioxide Koeneman et al. 
2010 
Caco2 K1-N0 
 
Three additional articles were identified during the review of the identified articles in the literature 
search. These were a paper by Kolashnjajtabi et al. 2010 concerning carbon nanotubes, a paper by 
So et al. 2008 concerning silicium dioxide and a paper by Hillyer and Albrecht 2001 concerning 
gold. These papers were considered of sufficient quality to be included in the phase II of this 
project. 
2.2 Description of the database 
2.2.1 Reference Manager database 
As already described in section 2.1.2 condensed information about all original peer-reviewed papers 
has been downloaded to Reference Manager 11 software (network version). The inserted user 
defined keywords allowed for sorting the papers not only by the available database information 
(such as author, journal, publication year etc.), but also by type of particle and study (i.e. in vivo, in 
vitro and synthetic).  
2.2.2 Extraction of information into spreadsheet format 
Information contained in each paper in the Reference Manager database was extracted, evaluated 
by the experts of the project team and appropriate scores allocated. The spreadsheet contains 21 
criteria (Klimisch criteria) and 10 criteria describing the characterisation of the investigated NPs. A 
score “1” or “0” means that the criterion has been complied with or not complied with, respectively. 
A subset of the Klimisch criteria was deemed of particular importance for the overall evaluation and 
is marked in red (figure 4). Failing to comply with these criteria may have led to a down-adjustment 
of the initially assigned category. 
FIGURE 4 EXAMPLE OF ALLOCATION OF KLIMISCH SCORE AND CHARACTERISATION SCORE.  
Article ID (e.g. Kong2004a) Loeschner2011 
nominal particle type (e.g. silver, gold, fullerene)  Silver 
Coatning PVP 
Other phys Chem parameters e.g. chrystalinity  - 
    
nominal particle diameter (in nm)  14 
Mechanistic absorption study (no tox, no Klimisch eval.)   
Evaluation of the study according to Klimisch - Answer "0" 
(no) or "1" (yes): 
  
1. Was the test substance identified?  1* 
2. Is the purity of the substance given?  1 
3. Is information on the source/origin of the substance given? 1 
4. Is all information on the nature and/or physico-chemical 
properties of the test item given, which you deem 
indispensable for judging the data (see explanation for 
examples)? 
1 
5. Is the species given? 1* 
6. Is the sex of the test organism given? 1 
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7. Is information given on the strain of test animals plus, if 
considered necessary to judge the study, other specifications 
(see explanation for examples)? 
1 
8. Is age or body weight of the test organisms at the start of 
the study given? 
1 
9. For repeated dose toxicity studies only (give point for other 
study types): Is information given on the housing or feeding 
conditions? 
1* 
10. Is the administration route given? 1* 
11. Are doses administered or concentrations in application 
media given? 
1 
12. Are frequency and duration of exposure as well as time-
points of observations explained? 
1 
13. Were negative (where required) and positive controls 
(where required) included (give point also, when absent but 
not required, see explanations for study types and their 
respective requirements on controls)? 
1 
14. Is the number of animals (in case of experimental human 
studies: number of test persons) per group given? 
1* 
15 .Are sufficient details of the administration scheme given 
to judge the study (see explanation for examples)?  
1* 
16. For inhalation studies and repeated dose toxicity studies 
only (give point for other study types): 17. Were achieved 
concentrations analytically verified or was stability of the test 
substance otherwise ensured or made plausible?   
1 
17. Are the study endpoint(s) and their method(s) of 
determination clearly described? 
1* 
18. Is the description of the study results for all endpoints 
investigated transparent and complete? 
1* 
19. Are the statistical methods applied for data analysis given 
and applied in a transparent manner (give also point, if not 
necessary/applicable, see explanations)? 
1 
20. Is the study design chosen appropriate for obtaining the 
substance-specific data aimed at (see explanations for 
details)? 
1* 
21. Are the quantitative study results reliable (see 
explanations for arguments)? 
1* 
sum 21 
Numerical result leads to initial Category:  1 
Checking * scores leads to revised Category: 1 
  
Evaluation of the NP characterization according to Card et al - 
Answer "0" (no) or "1" (yes) 
 
1. Agglomeration and/or aggregation 1 
2. Chemical composition  0 
3. Crystal structure/crystallinity  0 
4. Particle size/size distribution 1 
5. Purity 0 
6. Shape 1 
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7. Surface area 0 
8. Surface charge 1 
9. Surface chemistry (including composition and reactivity) 0 
10. Whether any characterization was conducted in the 
relevant experimental media. 
1 
score 5 
  
Evaluation of the information regarding absorption of NPs - 
Answer with text 
- 
Was the absorption process itself studied? No 
Which method was used to detect the NPs? ICP-MS 
Did the method allow to prove that the NPs in tissues were the 
pristine NPs? 
Yes 
Was the absorption rate determined? No 
Further results / conclusions - 
The resulting score of the example paper in figure 4 was K1-N5. 
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2.3 Quality assurance of the search strategy 
The quality assurance auditor observed that the documentation of the selection process was 
following the recommendations in EFSA guidance for those carrying out systematic reviews (EFSA 
2010). It was also observed that the acceptance criteria for the search terms were based on an 
expert evaluation.  
To validate the selected references the project coordinator made a list of relevant references based 
on earlier studies (ENRHES 2009), (Mikkelsen et al. 2011) and relevant original papers already 
known to the DTU project group considered pertinent to retrieve by the chosen search strategy 
before the search procedure with selection of references took place. This list was used as a 
comparator. Of these references, one was missing and one was an old reference without the key 
selection word “nano-”. Retrospectively, the missing reference was reassessed by the project 
coordinator and found to be less relevant for absorption after oral exposure (measurement of 
oxidative damages in different organs). 
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3. Phase II: Review of current 
knowledge on absorption of 
different nanomaterials 
after oral exposure 
In this chapter the literature of acceptable quality (see chapter 2.1.3) is summarized. The usage of 
each nanomaterial is shortly described. The “key study” for each nanomaterial is summarized and a 
short description with the most important data is given for “supplementary studies”. A final 
conclusion on each nanomaterial includes 1) identified data gaps in relation to the requirements in 
the EFSA guidance on risk assessment of nanomaterials 2) future research needs and 3) evaluation 
of factors influencing systemic absorption of nanomaterials after oral exposure. These items are 
based on in vivo studies.  
The in vitro studies included in the database are evaluated for relevance for human absorption. 
 
3.1 Carbon nanotubes  
3.1.1 Usage  
Carbon nanotubes (CNTs) are seamless cylindrical structures comprising single or multiple 
concentric graphene sheets. Single-wall CNTs (SWCNTs) have a diameter of 1–2 nm and a length of 
up to 100 µm. Multi-wall CNTs (MWCNTs) consist of several layers of carbon cylinders, which 
increase the diameter to 10–30 nm. They possess unique electrical, mechanical, and thermal 
properties, with a potential for a wide range of applications in electronics, computer, aerospace, 
architecture, and other industries. CNTs have the strongest tensile strength of any synthetic fibre. A 
composite material containing CNTs may have great strength, potentially sufficient to allow the 
building of spacecraft structures, space elevators, artiﬁcial muscles, combat jackets, membranes for 
gas separation and land and sea vehicles (Lam et al. 2006). In addition, CNTs are of special interest 
as potential tools for biomedical applications (Kolasnjajtabi et al. 2010), in which suitable modified 
CNTs can serve as drug delivery systems (Bianco et al. 2005). 
3.1.2 In vivo studies 
Absorption following oral exposure to CNTs has not been studied in experimental animals. Five 
papers that deal with oral toxicity of CNTs in laboratory animals did not measure levels of CNTs in 
blood and/or tissues, thus providing only indirect evidence for absorption of CNT related materials. 
These studies are summarized in the following. 
(Kolasnjajtabi et al. 2010) investigated granuloma formation and the toxicity after large doses of 
ultra-short and full-length SWCNTs in Swiss mice. Three different SWCNTs, were investigated. 
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Suspended by ultrasound in 0.9% aqueous NaCl solution containing 0.1% Tween 60: raw SWCNTs 
(R-SWCNTs), purified SWCNTs (P-SWCNTs) and ultrashort SWCNTs (US-SWCNTs) were 
characterized with respect to a number of metrics, including diameter, length, iron content, and 
surface area. The US-SWCNTs had a diameter of 1 nm and were 20-80 nm in length whereas the 
length of the two other CNTs was in the micrometer size range. Transmission electron microscopy 
(TEM) was used to image the CNTs in suspension and in tissues, urine and faeces following 
administration. TEM micrographs showed that the R- and P-SWCNT suspensions used were mainly 
composed of tangled flexible bundles of nanotubes, while the US-SWCNT suspensions were mainly 
composed of short, compact bundles of aggregated US-SWCNT. 
In an acute oral toxicity test, Swiss mice (10 per group) received a single oral bolus dose of 1000 
mg/kg bw of either R-SWCNTs, P-SWCNTs or US-SWCNTs and were sacrificed after 14 days. 
Irrespective of length, surface area, surface interaction, or iron content of the CNTs, no granuloma 
formation or acute oral toxicity was observed after a single bolus administration of up to 1000 
mg/kg bw in mice. It was not shown in this study, whether the CNTs was absorbed.  
In order to ensure full systemic bioavailability, the CNTs were administered to the mice by intra-
peritoneal injection (i.p.). Groups of six mice were administered the three different SWNTs at 
single, increasing i.p. doses (50, 300, and 1000 mg/kg bw for the US-SWCNTs and 50, 300, and 
500 mg/kg bw for the R- and P-SWCNTs). The animals were kept under observation until day14 
when sacrificed.  
Granulomas loaded with large CNT aggregates (mostly >10 µm in length) exhibiting fibre-like 
structures, were mainly formed by phagocytic cells and foreign body giant cells on the organ 
surfaces. However, in contrast to the short, compact bundles of US-SWCNTs, the large SWCNT 
bundles did not diffuse inside the organs. This explains the scarcity of granulomas inside the organs 
in the case of the large SWCNTs. Smaller aggregates did not induce granuloma formation, but they 
persisted inside cells. Short (<300 nm) well-individualized SWCNTs could escape the 
reticuloendothelial system to be excreted through the kidneys and bile ducts. In parallel with 
granuloma formation, numerous SWCNT aggregates smaller than 10 µm in length were observed 
within phagocytic cells of liver and spleen without subsequent granulomatous reaction. In some 
cases, small CNT aggregates were observed inside Ito cells similar to what occurs for fullerene. In 
very few cases, small US-tube aggregates were observed inside renal tubule epithelium cells. 
Microscopic examinations of all other organs (heart, lungs, and brain) did not reveal any deposit of 
the injected material, indicating that under these conditions most of the injected material was 
captured by the liver and spleen. 
Conclusion: No granuloma formation or acute oral toxicity was observed after single oral bolus 
doses of up to 1000 mg/kg bw to mice of either R-SWCNTs, P-SWCNTs or US-SWCNTs, 
irrespective of length, surface area, surface interaction, or iron content of the SWCNTs. Because 
after intraperitoneal administration, SWNTs, irrespective of their length or dose (50-1000 mg/kg 
bw), could coalesce inside the body to form fiber-like structures, that when structure lengths 
exceeded 10 µm, they irremediably induced granuloma formation. Smaller aggregates did not 
induce granuloma formation, but they persisted inside cells for up to 5 months after administration 
this could indicate no or low oral absorption of the SWNTs.  
Lim and co-workers (Lim et al. 2011a and Lim et al. 2011b) administered 0 (control), 40, 200 or 
1000 mg multi-wall CNTs (MWCNTs)/kg bw/day orally by gavage to pregnant Sprague-Dawley rats 
(N=12/group) from gestation days 6 through 19. The MWCNTs used were commercially available 
with a nominal diameter of 10-15 nm and length around 20 µm. The purity was stated to be 95% 
carbon and approximately 5% iron. The authors did not embark on any physico-chemical 
characterization and did not determine if aggregation of the CNTs occurred following the only 3 
minutes ultrasound treatment in 0.1% carboxymethylcellulose (stabilizer) solution in water. 
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According to the authors the no-observed–adverse-effect-level (NOAEL) was 200 mg MWCNTs/kg 
bw/day for maternal toxicity and 200 mg MWCNs/kg bw/day for developmental toxicity.  
Conclusion: This study was not designed to be an absorption study, but, the toxic effects seen at 
the highest oral dose (1000 mg/kg bw/day), might give some indirect indication that material 
related to the MWCNTs was absorbed. 
Matsumoto and co-workers (Matsumoto et al. 2012) studied the acute and 28-days subchronic 
toxicity of single wall SWCNTs or MWCNTs following administration of the test materials by gavage 
to Crl:CD (SD) rats. No acute toxicity was seen after SWCNTs and MWCNTs doses up to 50 mg/kg 
bw and 200 mg/kg bw, respectively, and no subchronic toxicity was seen after doses up to 12.5 
mg/kg bw/day of tSWCNTs (N= 5 or 10/sex/group), or 50 mg/kg bw/day for MWCNTs (N=6 or 
12/sex/group) the highest doses tested  
The purity of the SWCNTs and MWCNTs were >95% and they were principal samples in the OECD 
Sponsorship Programme on the Testing of Manufactured Nanomaterials. The structure of SWCNTs 
was described as honeycomb carbon lattice rolled into cylinder with diameter of around 2 nm mixed 
with bundles with diameters of several tens of nanometres. The structure of MWCNTs was carbon 
lattices rolled into a multi-layer tubular shape with diameter of around 30 nm. None of the 
materials were coated or modified. The vehicle used for stabilization of the ultra-sound suspended 
test suspensions was 5% gum acacia in aqueous solution. The homogeneity of test suspensions was 
confirmed by light microscopy.  
Conclusion: The authors suggested that SWCNTs and MWCNTs dosed by gavage reached the 
gastro-intestinal tract as agglomerates and were mostly excreted via faeces but no investigations 
and results to support this suggestion were presented. 
Awasthi and co-workers (Awasthi et al. 2013) administered male Swiss albino mice (N=6/group) 
single doses of 0 (vehicle control, distilled water), 60, or 100 mg/kg bw) of MWCNTs and studied 
hepatotoxicity on post dosing days 7, 14, 21 and 28 using liver SOD and CAT activity and 
microscopic examination as end-points. The tested MWCNTs, which were synthesised by chemical 
vapour deposition (CVD) technique, were purified and washed to remove metallic and 
carbonaceous impurities. Their size range was determined by SEM as 20–30 nm and length of 5–50 
µm. The testing suspensions were made by physical mixing and ultrasonication of surface-oxidised 
material, but any further data on characterization or aggregation was missing.  
Slight hepatotoxicity was reported at both dose levels, however, no incidences of the lesions were 
presented to enable comparison with the control group and support their relation to the treatment. 
Conclusion: The study does not support that any oral absorption of the test material occurred in 
mice. 
Sachar and Saxena (Sachar and Saxena 2011) administered single doses (100 µg/animal) of either 
SWCNTs or acid functionalized SWCNTs (AF-SWCNTs) to inbred Swiss and C57BL76 female mice 
(6–12 week old, weighing 20-25 g; number per group not reported) by either intratracheal 
instillation, intravenous (i.v.) or intra-peritoneal (i.p.) injections, or orally by gavage. The acid 
functionalized (AF)-SWCNTs were surface oxidized by a mixture of nitric and sulphuric acid under 
pressure at elevated temperature. The carboxylic acid moieties formed were derivatised by a 
fluorophor for imaging purposes, and were intensively purified to remove excess fluorescent dye. 
The particle size distribution and surface charge was not indicated. 
A transient decrease was observed in the number of erythrocytes and levels of blood haemoglobin 
(from 3 to 48 hours but not after 72 hours) after i.v. injection and to a lesser extent after i.p. 
injections of AF-SWCNTs as compared to SWCNTs. Administration of AF-SWCNTs through oral 
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gavage and the i.p. route did not reduce erythrocyte count (haemoglobin was apparently not 
measured for these routes of as no information is given in the paper).  
Conclusion: The study did not give any indication that the SWCNTs were absorbed in mice via the 
oral route of exposure.  
3.1.3 In vitro studies 
Four in vitro studies concerning toxicity of CNTs were identified. These gave indirect information 
on absorption. Jos and co-workers (Jos et al. 2009) exposed differentiated and non-differentiated 
Caco-2 cells (a cell line established from a human colon carcinoma, used as an enterocytic model) to 
carboxylic acid functionalized SWCNTs (COOH-SWCNTs) to concentrations between 5 and 1000 µg 
COOH-SWCNTs/ml for 24 hours. The average diameter of individual SWCNT was 1.4 ± 0.1 nm, and 
bundle dimensions were 4-5 nm x 0.5–1.5 µm (according to the provider). The COOH-SWCNTs had 
a content of nickel around 5-10%. Test suspensions were prepared in serum-free medium. After 24 
hours of exposure a concentration dependent trend in cytotoxicity (based on neutral red uptake, 
tetrazolium salt metabolisation, LDH leakage, viability, and histopathology) was seen, becoming 
clear at a concentration of 100 µg/ml COOH-SWCNTs. Agglomerates observed in some of the cells 
exposed to higher concentrations of the test material were considered by the authors of the study to 
be agglomerates of non-dispersed COOH-SWCNTs.  
Conclusion: This in vitro study may suggest that COOH-SWCNTs were absorbed or could enter 
the cells under the conditions of this assay, but only gave limited information on the potential 
absorption in humans after oral exposure. 
Szendi and Varga (Szendi and Varga 2008) studied the possible genotoxicity of SWCNTs (<2nm x 
4–15 µm, purity: 90%) and MWCNTs (10-30 nm x 1-2 µm; purity: 95% - 98%) dispersed in 
carbopol-based semiliquid gel. Urine samples obtained 24 hours after treatment by oral gavage of 
Fischer-344 male rats (N=3/group) with single doses of 0 (vehicle) or 50 mg/kg bw of SWCNTs or 
MWCNTs, were 10x concentrated and were tested in bacterial mutation assay (Ames test) in 
Salmonella typhimurium TA98 and TA100 strains with and without metabolic activation. Oral 
exposure to the nanotubes did not increase urinary mutagenicity under the conditions of the assay. 
In addition, no genotoxic effects of SWCNTs or MWCNTs were found in the in vitro micronucleus 
and sister chromatid exchange assays using human lymphocytes. 
Conclusion: The negative results of these assays neither proved nor exclude the absorption of NPs 
into the test cells.  
Cicchetti and co-workers (Cicchetti et al. 2011) exposed human gingival fibroblasts in semiconfluent 
cultures to SWCNT concentrations between 50 and 150 µg SWCNTs/ml for 24 hours. The SWCNTs 
used were oxidized by treatment with a mixture of nitric and sulphuric acids. The surface area of 
was 407 m2/g, and the average external diameter was 1.58 nm ± 0.20 nm and the average length 
was 0.76 µm ± 0.70 µm. The SWCNTs were reported by the authors to have “a relatively high degree 
of crystallinity”. The authors reported a genotoxic effect ([DNA damage by the alkaline comet assay 
(from 75 µg/ml) and increase (at concentrations up to 100 µg/ml) or decrease (125 and 150 µg/ml) 
in the frequency of micronuclei]), decrease in cell proliferation and survival (125 and 150 µg/ml), 
increase in reactive oxygen species production (at all concentrations) and Hsp70 induction (at all 
concentrations). 
Conclusion: The effects seen in vitro indicated that SWCNT related material was absorbed into 
the cells, but did not prove the absorption of any intact nanomaterial. 
Sachar and Saxena (Sachar and Saxena 2011) investigated the uptake of either SWCNTs or acid 
functionalized SWCNTs (AF-SWCNTs) in erythrocytes isolated from Swiss or C57BL76 female mice. 
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The acid functionalized (AF)-SWCNTs were surface oxidized by a mixture of nitric and sulphuric 
acid under pressure at elevated temperature. The carboxylic acid moieties formed were derivatised 
by a fluorophor for imaging purposes, and were intensively purified to remove excess fluorescent 
dye. The particle size distribution and surface charge was not indicated. Particle size distribution 
and surface charge on AF-SWCNTs were reported before (Saxena et al. 2007 as cited in (Sachar and 
Saxena 2011). 
A dose and time dependent decline (70 to 90%) in erythrocyte recovery was recorded in cultures 
treated with AF-SWCNTs (concentrations of 10, 25 or 50 µg/ml), while treatment with SWCNTs (50 
µg/ml) had no effect on erythrocyte recovery as compared to the untreated control groups. 
Furthermore, the authors reported an increase in the binding of 8-anilino naphthalene sulfonic acid 
to erythrocytes treated with AF-SWCNTs, which according to the authors indicated a significant 
damage of the erythrocyte membrane after exposure to the AF-SWCNT NPs. When erythrocytes 
freshly derived from female C57BL/6 mice were incubated with an AF-SWCNT preparation (50 
µg/ml) tagged with a fluorescence probe, 69% of the erythrocytes were positive for fluorescence 
indicating an uptake or association with AF-SWCNT. After washing 18.40% of the erythrocytes were 
still positive for fluorescence. This suggested that AF-SWCNTs could associate with erythrocytes in 
a loose as well as a relatively stronger manner. Examination by confocal microscopy of erythrocytes 
incubated with fluorescence tagged AF-SWCNTs showed the localization of fluorescence in 
erythrocytes.  
Conclusion: This study suggested that some fluorescence related to exposure to fluorescence 
tagged AF-SWCNTs could enter erythrocytes, but no clear evidence about absorption of the intact 
NPs after oral exposure to SWCNT was provided. 
3.1.4 Synthetic set-ups 
One study was identified, which investigated the adsorption of phenanthrene on CNTs and the 
bioavailability of adsorbed phenanthrene in simulated gastric fluids (a pepsin solution (a simulation 
of a gastric environment) and a bile salt fluid (a simulation of intestinal environment) (Wang et al. 
2011). CNTs can be carriers of hydrophobic organic compounds (HOCs) because of their high 
adsorption affinity and capacity. Polycyclic aromatic hydrocarbons (PAHs) are used in the synthesis 
of CNTs and they can potentially be adsorbed on any raw CNTs. Sorption by CNTs may therefore 
alter the fate, motility and bioavailability of PAHs.  
Adsorption of phenanthrene on CNTs was suppressed in simulated gastric fluids. Pepsin and bile 
salts increased the desorbing of the phenanthrene fraction from CNTs (in less than 1 h). Forty three 
to 69% of phenanthrene was released from CNTs after desorption in the simulated gastric fluid and 
intestinal fluid with low bile salt concentration. Higher release of phenanthrene was recorded at 
high bile salt concentration (53-86%).  
Conclusion: The possible transmission of HOC contaminants to the human gastro-intestinal 
system along with CNTs should be considered when performing risk assessments of CNTs.  
3.1.5 Conclusion on the studies concerning systemic  absorption of CNTs 
following oral exposure 
None of the in vivo studies identified in the open literature for the purpose of this review measured 
absorption of CNTs after oral exposure of laboratory animals in terms of blood and tissue levels. 
Thus, the reviewed in vivo studies neither prove nor rule out any absorption of CNTs from the 
gastro-intestinal tract following oral administration. However, the lack of toxicity ob-served in 
animal treated with oral doses of CNS compared with the toxicity seen in animals after i.v. or i.p. 
administration indicated that either no or a very low absorption occurred after oral exposure.  
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One of the reviewed in vitro studies reported presence of agglomerates, which were considered by 
the authors to be non-dispersed COOH-SWCNTs in Caco-2 cells following the exposure via addition 
of these nanotubes to the culture media, and when examined by light microscopy (Jos et al. 2009). 
Corresponding examination by confocal microscopy of erythrocytes exposed to AF-SWCNTs 
suggested that some AF-SWCNTs could enter erythrocytes (Sachar and Saxena 2011). Whether this 
only occurred at cytotoxic concentration is not clear. These in vitro observations solely suggest that 
the CNTs may be able to enter the cells, but do not provide any basis to conclude that CNTs can 
cross the intestinal wall and enter into circulation. 
3.1.6 Evaluation of factors influencing systemic absorption of CNTs following 
oral exposure 
In light of the occurrence of mainly negative data on absorption of CNT following oral exposure no 
evaluation of factors influencing their systemic absorption can be given. 
3.1.7 Identification of gaps in current knowledge and future research needs in 
relation to CNTs 
Carbon is present in every living cell. Thus lack of techniques which can discriminate the con-tent of 
the exogenous carbon from CNTs from an abundant background of the endogenous carbon in the 
blood and other tissues may be a reason for lack of studies of absorption, organ distribution and 
excretion of CNTs following oral exposure. Despite its high price level, a possible future way to 
study CNTs (and other carbonaceous materials) would be to synthesize CNTs on the basis of 
enriched stable 13C sources or by irradiation of naturally abundant carbon isotopes to generate in 
situ the isotopically enriched nanomaterial. In principle, a similar approach could be taken using 
non-stable (radioactive) 14C, but this would be detrimental due to possible toxic effects. Selective 
detection of enriched 13C could be carried out by isotope ratio mass spectrometry against the natural 
abundance of this isotope. This however, requires covalent binding of the enriched stable 13C. A 
different strategy would be to insert markers (rare earth elements; fluorescent markers) and then 
detect the CNTs by way of such markers. Again, the stability of the marker is crucial for its practical 
use. Furthermore, because CNTs often are being used as their surface-derivatives (carboxy-, 
hydroxyl-, ammonium-, or possibly apolar moieties) a study of the influence of such derivatisations 
on intestinal uptake and translocation is missing. Hereby, more knowledge about the influence of 
surface charge on the possible intestinal uptake can be derived. The absorption, organ distribution 
and excretion of CNTs following oral administration remain to be established. 
The study by Sachar and Saxena (Sachar and Saxena 2011) demonstrated that AF-SWCNTs were 
more toxic to murine erythrocytes both in vivo and in vitro. This may suggest that the acid 
functionalisation of CNTs may affect their toxicity as compared to parent CNTs. Studies comparing 
toxicity of modified CNTs and non-modified ones may be needed in order to perform hazard 
identification and hazard characterization of the modified material. It cannot be ruled out that 
reading-across from toxicity data for non-modified CNTs may underestimate the toxic potential of 
modified CNTs 
 
3.2 Cerium dioxide 
3.2.1 Usage  
Cerium dioxide NPs (CeO2-NPs) have been developed as a fuel additive to reduce particulate matter 
emissions from diesel engines in an attempt to reduce the adverse health effects ordinarily 
associated with particulate exposure (Fall et al. 2007). Other potential industrial uses of CeO2-NPs 
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may be applications for solar cells, gas sensors, oxygen pumps, and glass/ceramic applications 
(Park et al. 2009). 
3.2.2 In vivo studies 
One relevant in vivo study on organ distribution after oral exposure was identified and is 
summarised below. 
Park and co-workers (Park et al. 2009) studied organ distribution of CeO2-NPs in a toxicity study 
where male SD rats received orally by gavage a single dose of 0 (control, distilled water, N=12), 100 
mg/kg bw (N=18) or 5 g/kg bw (N=18) of CeO2-NPs. The CeO2-NPs used in the study had 
crystallite size of 30 nm and were suspended in distilled water and was sonicated for 30 min before 
their administration to the animals. Scanning electron microscope (SEM) images of the CeO2-NPs 
justified that the material consisted of nanosized, but aggregated structures. The rats were 
sacrificed on days 1, 7 and 14 after treatment [N= 4 (control) or 6 (treated) per sacrifice]. 
Determination of CeO2-NPs in blood and tissues was not attempted. Ce concentrations were 
analysed in tissues from liver, kidney, spleen, lung, testis and brain using ICP-MS. 
There is not sufficient evidence for the statement that the crystallites indeed were 30 nm in size, 
and it therefore remains unclear to which size of CeO2-NPs that the animals were actually exposed. 
Increased levels of Ce, as measured by inductively coupled plasma mass spectrometry (ICP-MS), 
were found in all examined tissues of the animals treated with the highest dose while this only was 
seen in the lungs from animals given the low dose, when compared to the control values. This 
indicates a low degree of absorption of cerium following exposure to CeO2-NPs. No results were 
presented to demonstrate that Ce-containing NPs were detected in the tissues. 
No mortality occurred and no changes in clinical appearance, haematology, serum clinical 
chemistry parameters, and microscopically examination of liver, lung and kidney from animals 
sacrificed on day 14 after treatment. According to the authors of the study the reason for the lack of 
toxicity could be low absorption of the test material from the gastro-intestinal tract as indicated by a 
white colour of the faeces.  
Conclusion: The results of the study by Park and co-workers indicate low bioavailability of cerium 
after oral administration of CeO2-NPs. However, the study cannot clarify whether the absorption 
took place in the form of CeO2-NPs or as Ce ions, or a mixture of both.  
3.2.3 In vitro studies 
One relevant in vitro study was identified. 
Gaiser and co-workers (Gaiser et al. 2009) investigated the uptake of CeO2-NPs by C3A cells, a 
human hepatocyte cell line, and Caco-2 cells, a human intestinal epithelial cell line. The CeO2-NPs 
were <25 nm (CeO2-NPs) and <5 µm (bulk CeO2) in nominal size. The particles were dispersed by 
sonication at 1 mg/ml in culture medium for 15 minutes. 
To assess particle uptake C3A cells plated on glass cover-slips and Caco-2 cells plated on Transwell 
membranes were incubated with media only (negative controls) or particles suspensions at 3.125 
and 31.25 µg/cm2 of CeO2 of both sizes for 2 hours (C3A) or 24 hours (Caco-2). According to the 
authors of the study both sizes of CeO2 were taken up into both C3A and Caco-2 cells but data to 
document this statement were not given in the paper. 
Conclusion: This in vitro study was not adequately reported to judge on the potential uptake of 
CeO2-NPs in human hepatocytes or enterocytes.  
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3.2.4 Synthetic set-ups 
No relevant studies were identified. 
3.2.5 Conclusion on the studies concerning systemic absorption of CeO2-NPs 
following oral exposure 
The only in vivo study available measured the organ distribution of Ce after oral administration of 
CeO2-NPs (Park et al. 2009) to rats and found low levels in major organs which indicated low ab-
sorption. Whether the absorption was in the form of Ce ions or as CeO2-NPs, or both, was not 
shown. The available in vitro study was not adequately reported to judge on the potential uptake of 
CeO2-NPs in human hepatocytes or enterocytes. 
3.2.6 Evaluation of factors influencing systemic absorption of CeO2-NPs 
following oral exposure 
The available literature do not provided data for an evaluation to be performed. 
3.2.7 Identification of gaps in current knowledge and future research needs in 
relation to CeO2-NPs 
Studies investigating the blood levels, faeces content and urine concentration of intact CeO2-NPs 
following oral exposure are necessary in future research to assess absorption and fate of the NPs in 
experimental animals. Studies comparing absorption, distribution and excretion of the same doses 
of CeO2-NPs and bulk CeO2 are needed to elucidate potential differences or similarities of fate in 
the body in order to decide whether read–across from toxicity data of the bulk material to 
nanoparticulate material would be justified for purpose of hazard identification and hazard 
characterization. Lastly, the possible dissolution behaviour of CeO2-NPs is not reported following 
per oral administration and should be investigated to allow evaluation of the nanoparticulate 
material vs. possible dissolved Ce species.  
 
3.3 Fullerenes  
3.3.1 Usage  
Several areas of use have been proposed for fullerenes such as targeted drug delivery (Vogelson 
2001), as 'molecular ball bearings', allowing surfaces to glide over one another, acting as a lubricant 
(Holister et al. 2003), as reinforcement of a polymer matrix which can lower the density of the 
resulting material. 
Fullerene C60, which is a ball-shaped molecule containing 60 carbon atoms, is used in cosmetics to 
reduce oxidative stress in the skin. Water soluble fullerene C60 may be used as whitening agent. 
Water soluble fullerene C60 derivatives were reported to show promise for the treatment of various 
inflammatory diseases (Yamashita et al. 2013). 
3.3.2 In vivo studies 
Two in vivo studies were identified; one of them investigated the oral absorption of a radio-labelled, 
water soluble fullerene in rats. The other study was an oral toxicity study, but absorption as such 
was not investigated. 
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Yamago and co-workers (Yamago et al. 1995) administered a single dose of 14C labelled water-
soluble C60 fullerene either orally (presumably by oral gavage, but this information was not given) 
(18 kBq) or by intravenous injection (i.v.) (9 kBq) to Fischer rats (N=3 males/group; body weight of 
85–95 g). Radioactivity was measured in the liver, spleen, lungs, kidneys, heart, brain, testes and 
blood for up to 160 hours after treatment, in faeces up to 2 days and in urine up to 30 hours. 
Following i.v. administration the radioactivity in the blood decreased rapidly and was distributed to 
various tissues, in particular the liver. In the liver, 73% of the total radioactivity was found after 1 
hour, the maximal amount of 92% was recorded after 16 hours, and after 30 hours 80% of the total 
radioactivity still pertained in the liver.  
Conclusion: Following oral administration, absorption of the water soluble fullerene was poor: 
Ninety-seven per cent of radioactivity was excreted in faeces within 48 hours and only trace 
radioactivity was found in the liver (and other tissues) after the 3 and 6 hour periods.  
Yamashita and co-workers (Yamashita et al. 2013) administered 6 weeks old female C57BL/6 mice 
(N=6-7/group) 0 (controls) or 50 mg/animal/day (equivalent to 2000 mg/kg bw/day) of 
polyvinylpyrrolidone (PVP)-wrapped fullerene C60 (PVP-fullerene C60) orally by gavage for 7 days. 
The PVP-fullerene C60 was used after 5 minutes of sonication and 1 minute of vortexing. The mean 
size and size distribution were measured by using dynamic light scattering; zeta potential was 
measured by using laser doppler electrophoresis. The particle size of PVP-fullerene C60 in distilled 
water was 127 nm, and its zeta potential was -2.2 mV. No effects were seen on body weights, 
hematological, and clinical chemistry parameters, organ weights and histology.  
Conclusion: No toxicity could be demonstrated in this oral toxicity study in mice given large doses 
of PVP-fullerene C60, which could indicate a low or absent oral absorption. 
3.3.3 In vitro studies 
No in vitro studies were identified for fullerenes. 
3.3.4 Synthetic set-ups 
No relevant studies were identified. 
3.3.5 Conclusion on the studies concerning  systemic absorption of fullerenes 
following oral exposure 
The only study identified, which compared the distribution of radioactivity after a single dose of 14C 
labelled water-soluble C60 fullerene following oral and intravenous administration indicates very 
limited, if any, absorption after oral exposure (Yamago et al. 1995). 
In the toxicity study by Yamashita and co-workers (2013) large oral doses of PVP-fullerene C60 did 
not induce toxic effects which could point to a low, or absent absorption. However, the absorption 
in terms of blood or liver levels of PVP-fullerene C60 was not measured. 
The presented results did not permit any conclusions concerning oral absorption of PVP-fullerene 
C60 and fullerenes. 
3.3.6 Evaluation of factors influencing systemic absorption of fullerenes 
following oral exposure 
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In light of the lack of data on absorption of fullerenes following oral exposure no evaluation of 
factors influencing fullerenes absorption can be performed. No conclusion on the effect of water 
solubility of fullerenes on absorption from gastro-intestinal tract can be drawn.  
3.3.7 Identification of gaps in current knowledge and future research needs in 
relation to fullerenes.  
Fullerenes are compounds consisting of carbon atoms. Fullerene C60 is a compound consisting of 
60 carbon atoms, with a diameter of approximately 0.7 nm while PVP-fullerene C60 is one of its 
water soluble derivative. Thus lack of techniques which can discriminate the content of the 
exogenous carbon from fullerenes from an abundant background of the endogenous carbon cells in 
the blood and other tissues may be a reason for lack of studies of absorption, organ distribution and 
excretion of fullerenes following oral exposure. Knowledge about any possible absorption, organ 
distribution and excretion of fullerenes following oral administration remain to be established. 
 
3.4 Gold 
3.4.1 Usage 
Gold NPs (Au-NPs) have been used for various biomedical applications due to their unique surface, 
electronic and optical properties. Because of their physico-chemical properties, including surface 
plasmon resonance, fluorescence, and easy surface functionalisation, Au-NPs have been widely used 
in biosensors, used for cancer cell imaging, photothermal therapy and for drug delivery. 
Furthermore, because of their rather high stability in liquid suspension, Au-NPs are often used for 
research applications as model NPs to study processes where a rather low degree of solubility of a 
NP is desirable.  
3.4.2 In vivo studies 
Three studies were identified. 
In a key study, (Hillyer and Albrecht 2001) investigated the gastro-intestinal uptake of metallic 
colloidal gold particles (Au-NPs) in mice. Instrumental neutron activation analysis (INAA) and 
transmission electron microscopy (TEM) were used to quantitatively and qualitatively study the 
gastro-intestinal uptake and subsequent tissue/organ distribution of 4, 10, 28, and 58 nm diameter 
unconjugated Au-NPs following oral administration to BALB/c mice (sex and animals/group not 
given) in the drinking water (the concentration was 0.2 mg/ml) for 7 days. 4 nm Au-NPs were 
identified at low levels in the following organs/tissues in descending concentrations: kidney, small 
intestine, lung, stomach, spleen, liver, heart, blood, and brain. In the quantitative studies, it was 
found that Au-NP uptake is dependent on particle size: smaller particles (4 and 10 nm) cross the 
gastro-intestinal tract more readily than larger ones (than 28 and 58 nm). Electron microscopic 
studies showed that particle uptake occurred in the small intestine by persorption (the paracellular 
up-take of particles from the digestive tract into the body) through single, degrading enterocytes in 
the process of being extruded from a villus.  
Conclusion: This study demonstrated that Au-NPs were absorbed from the gastro-intestinal tract 
at low levels by uptake of particulates by persorption through holes created by extruding 
enterocytes in the small intestine. Au-NP uptake was dependent on particle size: smaller particles (4 
and 10 nm) crossed the gastro-intestinal tract more readily (than 28 and 58 nm). 
In a 14-day toxicity study Zhang and co-workers treated groups of male ICR mice (11 weeks old, six 
per group) with 13.5 nm citrate-stabilized Au-NPs by oral gavage at doses from 137.5-2200 μg/kg 
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bw/day (Zhang et al. 2010).Transmission electron microscopy (TEM) images were used for imaging 
of the Au-NPs in red blood cells and bone marrow cells from mice receiving 2200 μg/kg bw/day for 
14 days. Multiple vesicles containing Au-NPs were readily observed in the cells, and within the 
vesicles the Au-NPs appeared to be monodisperse. Many Au-NPs were observed outside of the cell 
membranes, and their average size was about 10–15 nm.  
Conclusion: The study showed that Au-NP related materials were absorbed following oral 
administration to mice and could be deposited in a “deep” pool such as the bone marrow.  
Jumagazieva and co-workers administered Au-NPs of three different sizes to deliver 0.25 mg Au/kg 
bw/day to groups of six male rats by oral gavage with the purpose of screening its in vivo 
genotoxicity (Jumagazieva et al. 2011). The rats received Au-NPs of 16 or 55 nm in diameter or gold 
nanoshells of 160 nm in diameter (consisting of a core of 120 nm silicium dioxide and a shell of 20 
nm Au) once a day for 7 days. To ensure stability and biocompatibility, the surface of NPs was 
functionalized with polyethylene glycol (PEG) molecules. 
Conclusion: Because no genotoxicity was seen and no attempts were made to detect Au-NPs in 
tissues the study cannot be used to make a judgement on intestinal absorption following oral 
exposure.  
3.4.3 In vitro studies 
No in vitro studies were identified for gold. 
3.4.4 Synthetic set-ups 
No relevant studies were identified. 
3.4.5 Conclusion on the studies concerning systemic absorption of Au-NPs 
following oral exposure 
Au-NPs were absorbed at low levels following oral administration, and were distributed to a 
number of organs in experimental animals by uptake of particulates by persorption through holes 
created by extruding enterocytes from the villi in the small intestine. 
3.4.6 Evaluation of factors influencing systemic absorption of Au-NPs following 
oral exposure 
Au-NP uptake was dependent on particle size: smaller particles (4 and 10 nm) crossed the gastro-
intestinal tract more readily than 28 and 58 nm particles. 
3.4.7 Identification of gaps in current knowledge and future research needs in 
relation to Au-NPs 
It is well-know that Au-NPs attract a corona of available proteins and other biomolecules. There-
fore, a detailed study of the fate and formation of aggregates/corona in the GI tract is needed to 
improve understanding of the fate of particles in the gastro-intestinal environment and their 
absorption from the gastro-intestinal system in order to evaluate whether read across of data on 
other gold compounds/metallic gold to nanoparticulate material could be justified when assessing 
toxicity of Au-NPs after oral administration. 
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3.5 Iron oxide 
3.5.1 Usage  
Iron oxide nanoparticles (Fe2O3-NPs) are applied in magnetic resonance imaging (MRI) for 
contrast enhancement to identify metastases from inflammatory lymph nodes, to provide 
information on tumour angiogenesis, to differentiate dangerous atherosclerotic plaques, and to 
differentiate healthy and pathological tissues. Other applications are to induce magnetic 
hyperthermia (one of the therapies for cancer treatment) or as carriers for targeted drug delivery in 
treatment of various forms of cancer (Singh et al. 2013). 
3.5.2 In vivo studies 
Two relevant in vivo studies on absorption of Fe2O3-NPs after oral exposure were identified and 
are summarised below. 
The key study is a study by Singh and co-workers (Singh et al. 2013).The tissue distribution (and 
genotoxicity) of nano and micro sized (bulk) Fe2O3 in rats were compared after acute oral gavage 
administration. Female Wistar rats (N=5/group/treatment/sampling time), 6-8 weeks old and 
weighing 80-120 g, were given single doses of vehicle (Milli Q water), and 500, 1000 or 2000 mg/kg 
bw of Fe2O3-NP (30 nm) or Fe2O3- bulk suspended in Milli Q water. The Fe2O3- bulk material had 
size of <5 µm and purity ≥ 99%. The size of the Fe2O3-NPs was < 50 nm (data from manufacturer). 
The mean size distributions of Fe2O3-NPs and Fe2O3-bulk were 29.75 nm and 2.15 µm 
respectively. The hydrodynamic diameter for Fe2O3-NPs in Milli Q water suspension was 363 nm. 
The results of DLS showed larger values than when measured by TEM, indicating that Fe2O3-30 
nm particles formed larger agglomerates in suspension. Zeta potential and electrophoretic mobility 
measurements were -18.6 mV and -1.47 µ (µm cm/V/s) respectively at pH 7.0. The specific surface 
area of Fe2O3-NPs and Fe2O3-bulk was 38.02 and 5.67 (m2/g), respectively. 
Blood and bone marrow samples were taken for genotoxicity testing (comet assay in peripheral 
blood lymphocytes, blood micronucleus test, and bone marrow micronucleus test and chromosomal 
aberration assay) and samples of whole blood, liver, kidneys, heart, brain, spleen and bone as well 
as pooled samples of urine and faeces were taken at fixed time points up to 48 hours after dosing for 
studies of iron absorption and organ distribution. 
Neither Fe2O3-NPs nor Fe2O3-bulk produced genotoxicity under the conditions of the bioassays. 
In the animals treated with Fe2O3-NPs significantly increased concentrations of iron were 
measured in the blood and all examined tissues, except the brain, when compared to the controls. 
At all time points and for all doses the highest iron concentrations were recorded in descending 
order for blood, spleen, liver, kidney, heart, bone marrow. No significant increase of iron was 
detected in the brain. The incorporation of iron from Fe2O3-NPs in the various tissues was in the 
range of 0.2 - 9.4%.  
In animals treated with Fe2O3- bulk no significant increase in iron concentration was recorded in 
kidneys, heart, blood and urine when compared to the controls, while significantly increased 
concentrations of iron were detected in the liver and spleen. The incorporation of iron in the various 
tissues was in the range of 0.01 – 2.3% in the Fe2O3- bulk treated groups. 
In the rats treated with Fe2O3- bulk the urinary concentrations of iron were not significantly 
different from the control values and were much lower than in the rats treated with the 
nanoparticulate material. 
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Based on the results on the distribution and levels of iron in organs of rats it can be concluded that 
iron was more efficiently absorbed from the gastro-intestinal tract following administration of 
Fe2O3-NPs than of the bulk material.  
Conclusion: The bioavailability of iron from Fe2O3-NPs was significantly higher than from 
Fe2O3- bulk when administered orally to rats. However, the study was not able to clarify whether 
the iron is absorbed in the form of nanomaterial or as ions liberated in the gut, or both. 
McCullough and co-workers (McCullough et al. 1995) studied uptake and translocation of 
particulate iron across the gastro-intestinal mucosa. Male Sprague-Dawley rats (6-8 weeks old, 
N=6/group), fasted for 24 hours, were fed ad libitum either milk (control) or a suspension of iron 
powder (metallic iron, particles ranging in size from 6-9 µm down to 5-30 nm) suspended in milk (5 
g powder/100 ml milk). The size of the iron particles was only given in the abstract, while in 
Materials and Methods the iron powder was referred to as “iron powder 6-9 micron”. Samples from 
duodenum were taken from control and treated rats 24 hours after the dosing. The samples were 
processed and subjected to examination by light microscopy, scanning electron microscopy (SEM), 
transmission electron microscopy (TEM) and X-ray microanalysis (XRMA). 
Iron deposits were observed within the tissue of the duodenum by light microscopy. SEM revealed a 
selective localization of iron in the villi with variation in levels of iron uptake by the mucosal cells. 
Ultrastructural and XRMA analysis of duodenum samples established the presence of metallic iron 
NPs within the brush border, lateral intercellular spaces of the mucosal cells, mitochondrial cristae 
and cytoplasm of both mucosal and stromal cells. 
Conclusion: According to the authors their results indicated that metallic iron particles, in the 
nano-size range may be taken up by the gastro-intestinal mucosa and that the passage of such 
particles across the epithelium barrier may take place through both a paracellular as well as 
transcytotic process. 
3.5.3 In vitro studies 
No in vitro studies were identified for iron. 
3.5.4 Synthetic set-ups 
No relevant studies were identified. 
3.5.5 Conclusion on the studies concerning systemic absorption of iron oxide 
following oral exposure 
One study (Singh et al. 2013) investigated the levels of iron in blood and major organs of rats 
following administration by gavage of nano-sized and bulk Fe2O3. It can be concluded that iron was 
more efficiently available to organs and tissues from Fe2O3-NPs than from the bulk material. 
However, this study was not able to clarify whether the iron was absorbed in the form of the 
nanomaterial or as Fe-ions liberated in the gut, or both. In another study it was shown, that metallic 
iron NPs can be taken up by the gastro-intestinal mucosa and that the passage of such particles 
across the epithelia barrier may take place through both a paracellular as well as a transcytotic 
process. 
3.5.6 Evaluation of factors influencing systemic absorption of iron oxide 
following oral exposure 
The results by Singh and co-workers (2013) indicate that the oral absorption of iron was higher for 
Fe2O3-NPs compared to the bulk material. Thus the size of the particles may influence absorption. 
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This is supported by the findings by McCullough and co-workers that indicated that metallic iron 
particles in the nano-size range was taken up by the gastro-intestinal mucosa and crossed the 
epithelia barrier through both paracellular as well as transcytotic processes  
3.5.7 Identification of gaps in current knowledge and future research needs in 
relation to iron oxide 
Although the study by Singh and co-workers (2013) demonstrated that iron is better absorbed from 
Fe2O3-NPs than from the bulk material, it is not clear whether the iron was absorbed as NPs or in 
ionized form, or both. Studies to clarify this issue are missing for Fe2O3. 
 
3.6 Selenium  
3.6.1 Usage  
Selenium NPs (Se-NPs) have found use in food supplements and nutraceutical products as an 
alternative source of the essential trace element Se. The background for its use is that the acute 
toxicity is lower than that of sodium selenite, which is commonly used in food supplements and 
nutraceutical products.   
3.6.2 In vivo studies 
No in vivo studies were identified for selenium. 
3.6.3 In vitro studies 
Only one study was identified. 
Wang et al. (Wang and Fu 2012) investigated the uptake of selenium (Se) into Caco-2 cells from 
sodium selenite, Se-NP and selenomethionine by measuring the activity of the selenium containing 
antioxidant enzyme glutathione peroxidase. The sizes of red elemental Se-NPs were 60–80 nm as 
determined by dynamic light scattering with the average size of 69 nm. The transport and uptake of 
the three different forms of Se (all at 0.1 μmol l−1) across a Caco-2 cell monolayer were carried out 
for 2 hours and the uptake efficiencies were calculated. The highest uptake efficiency was observed 
in cells treated with Se-NPs. Because the Se content of all samples was determined by atomic 
absorption spectrometry following dissolution of the specimens in acid, no information was 
obtained about any intact Se-NPs in the samples. 
Conclusion: The study demonstrated that the transport and uptake of Se from Se-NPs were time-
dependent and the epithelial transport across Caco-2 cell monolayers mainly occurred via passive 
transport pathways. In addition, the results strongly indicated that Se-NPs existed as dissolved 
species in order to make the incorporation into the bioactive enzyme possible. The membrane 
passage of Se dosed as Se-NPs was superior to that provided by the two other tested molecular Se 
species. 
3.6.4 Synthetic set-ups 
No relevant studies were identified. 
3.6.5 Evaluation of factors influencing systemic absorption of Selenium 
following oral exposure 
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The membrane passage of Se dosed as Se-NPs was time-dependent and mainly via passive 
transport. Further, was the membrane passage of Se-NPs superior to that provided by the two other 
tested molecular Se species. 
3.6.6 Identification of gaps in current knowledge and future research needs in 
relation to selenium 
The biological effects and efficacy of Se-NPs need further elucidation. The possible uptake of 
pristine Se-NPs by cells, or the possible deposition of elemental Se0 following high doses of soluble 
salts, is an area of future research by EM-based techniques (imaging in cells) and by combined 
methods involving size-separation coupled with atomic spectrometric detection of Se. 
 
3.7 Silicium dioxide 
3.7.1 Usage  
Silicium dioxide nanoparticles (SiO2-NPs) can be divided into two major varieties; crystalline and 
amorphous SiO2-NPs. Crystalline SiO2-NPs may occur in several different forms, including quartz, 
cristobalite and tridymite. Amophous SiO2-NPs can occur as mesoporous and amorphous SiO2-
NPs. SiO2-NPs are used for numerous applications such as ingredients in cement, paints, solid 
lubricants, shampoos, cosmetics and facial creams. Further potential applications are in bio-
electrochemistry, curing, oil recovering applications and formulation of other particles (Mikkelsen 
et al. 2011). 
Synthetic amorphous SiO2-NPs (SAS) have been used for many years in food applications, such as 
for clearing of beers and wines, as anticaking agent to maintain ﬂow properties in powder products 
and to thicken pastes. The conventional form of amorphous SiO2-NPs is known as the food additive 
E 551 (EFSA 2009a). Synthetic amorphous SiO2-NPs in principle do not contain crystalline SiO2-
NPs. Although synthetic amorphous SiO2-NPs is permitted for application in food, it probably has 
not been tested with a focus on the nanometre sizes of SiO2-NPs (Dekkers et al. 2012). According to 
(ECETOC et al. 2006) commercial SAS does not fall into the class of NPs. However, Dekkers et al, 
2011 have measured the particle size of SiO2-NPs in several food products to be in the range of 50 
to 200 nm. In a processed food product (hot coffee with creamer) it was between 30 and 120 nm 
(Dekkers et al. 2011).  
3.7.2 In vivo studies 
Only one study was identified. 
Limited information was available on the absorption of SiO2-NPs after oral ingestion. In a limited 
study, (So et al. 2008) So et al. reports an oral repeated-dose toxicity study with nanosized SiO2-
NPs (30–90 nm, obtained from rice husk, not further speciﬁed). Groups of Balb/c mice (5 males 
and 5 females per group) were fed either normal diet (control), 1% nanosized SiO2-NPs diet or 1% 
microsized SiO2-NPs (0.5–30 nm) diet for 10 weeks. The silicium content was measured in lung 
and liver by ICP-AES. The exposure resulted in higher serum ALT (alanine aminotransferase) levels 
in mice dosed with SiO2-NPs compared to mice dosed with micrometre-sized (0.5–30 mm) SiO2 
and the control mice (So et al. 2008). However, the level of SiO2-NPs in the liver (and lung) of the 
nanoparticle dosed mice was lower than that of the micrometre-sized (0.5–30 mm) SiO2-NPs dosed 
mice and the control group.  
Conclusion: The results suggest that SiO2-NPs administered to mice via the diet (1%) during 10 
weeks can, to some degree, reach the systemic circulation. However, SiO2-NPs levels were lower in 
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these mice than in the control mice and the mice offered micrometre-sized (0.5–30 mm) SiO2-NPs. 
The study is not well reported and lacks some important details on, among others, the 
characterization of the SiO2-NPs both in the feed and in the organs. It is also remarkable that the 
effect increased ALT was only found for Balb/c mice and not for C57BL/6 mice. 
3.7.3 In vitro studies 
No relevant in vitro studies were identified on the absorption of nano-SiO2-NPs. However in a 
recent study by Peters et al, (Peters et al. 2012) the presence of SiO2-NPs during in vitro digestion 
of foods was investigated. In this study an in vitro model to mimic the human digestion was used. 
Different nanomaterials were investigated: 1) A commercially available food additive synthetic 
amorphous silica (SAS) with a primary particle size of 7 nm and a specific surface area of 388 m2/g. 
2) A 32 nm colloidal SiO2-NPs material, stabilized at pH 8.6, 3) a set of SiO2-NP suspensions with 
particle diameters of 100 and 500 nm. Different food products containing nano-SiO2-NPs was 
subjected to in vitro digestion included (i) hot water, (ii) coffee with powdered creamer, (iii) instant 
soup, and (iv) pancake which either contained SiO2-NPs as the food additive E551, or to which a 
form of synthetic amorphous SiO2-NPs or 32 nm SiO2 particles were added.  
The results showed that nano-sized (5-200 nm) SiO2-NPs is present in the saliva digestion stage in 
a relative amount of 5 to almost 40% when products containing E551 were tested. However, during 
the successive gastric digestion stage, the SiO2-NPs disappeared in the case of coﬀee and instant 
soup, while low amounts were found for pancakes in the gastric stage. The absence of nano-sized 
SiO2 is an effect of the low pH combined with high electrolyte concentrations in the gastric 
digestion stage. Large SiO2-NPs agglomerates are formed under this condition which is supported 
by DLS and SEM data. However, when the pH was increased to neutral pH in the intestinal stage, 
nano-sized SiO2-NPs reappears in even higher amounts than in the saliva stage. The results for 
coffee with E551 suggest that after complete digestion around 80% of SiO2-NPs are in the 
nanometre size range. For soup and pancake with E551, that is products containing more 
particulate and ﬁbrous matter, the amount of SiO2-NPs after complete digestion is around 15%. 
Conclusion: These findings suggest that, upon consumption of foods containing E551, the gut 
epithelium is most likely exposed to nanometre-sized SiO2-NPs. This is important because single 
SiO2-NPs may be more easily absorbed from the human intestine than agglomerates (Dekkers et al. 
2012). 
3.7.4 Synthetic set-ups 
No relevant studies were identified. 
3.7.5 Conclusion on the studies concerning systemic absorption of SiO2-NPs 
following oral exposure 
Only one limited in vivo study was identified, and therefore no firm conclusion can be drawn. 
However, in a recent in vitro study it was shown that after complete digestion of foods containing 
SiO2-NPs (E551) a high amount of SiO2-NPs is present in the gut, which may increase the bio-
availability of the substance. 
3.7.6 Evaluation of factors influencing systemic absorption of SiO2-NPs 
following oral exposure 
Due to lack of relevant data no conclusion can be drawn. 
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3.7.7 Identification of gaps in current knowledge and future research needs in 
relation to SiO2-NPs 
Although it has been estimated that the intake via food of SiO2 (nano + non-nano) is 9.5 mg/kg 
bw/day only very limited data on oral exposure are available. Dekkers et al. (Dekkers et al. 2012), 
have performed a very comprehensive review of the literature on different forms of SiO2-NPs. They 
identified knowledge gaps and gave some recommendations for future research needs, which are 
quoted below: 
The evaluation of the most recent information on SiO2-NPs as well as information on SAS leads to 
the conclusion that more information on the oral absorption and possible accumulation of SiO2-
NPs and SAS is needed. 
First, indications could be obtained by investigating the in vitro absorption/transport of SiO2-NPs 
with intestinal and dermal cell lines. Ideally, absorption, distribution and elimination could be 
studied by investigating blood kinetics and tissue distribution of SAS and nanoSiO2-NPs (as 
processed in food products) after single and preferably repeated oral administration in a rodent 
model. Special attention should be given to the possibility of accumulation of nano-SiO2-NPs in 
different tissues. If accumulation occurs, the extent and effects of this accumulation should be 
investigated. Depending on the tissues in which accumulation is expected to occur, the effects of the 
accumulation can be studied in a repeated-dose oral toxicity, reprotoxicity and/ or neurotoxicity 
study. These studies should be conducted with SiO2-NPs (comparable with the SiO2-NPs found in 
food products) and dose levels ranging from realistic exposure levels to toxic dose levels. 
 
3.8 Silver  
3.8.1 Usage  
Historically, silver salts have been used in pharmaceuticals because of its bacteriostatic effects, and 
the forms of administration were on skin as ointments or per orally as solutions. Nowadays, silver 
NPs (Ag-NPs) are the single most widespread type of NPs used in consumer products, and the 
number of products available on the market steeply increased in the late 2000s. Similarly to silver 
salts, Ag-NPs are used because of their bacteriostatic effects in e.g. clothing, household water filters 
and water bottles. The mechanism of their bacteriostatic effect is not completely clear, but it has 
been assumed that the effects of silver are linked to silver ions released from the large specific 
surface of Ag-NPs. If correct, then these NPs constitute a reservoir of the biologically active silver 
ions, which may become progressively released in concert with the existence of ligands with affinity 
to silver ions in the surroundings of the Ag-NPs.  
3.8.2 In vivo studies 
Seven studies were identified. 
The key in vivo study on intestinal uptake of Ag-NPs was authored by Loeschner et al. (Loeschner et 
al. 2011). This study investigated the distribution of silver in rats after 28 days repeated oral 
administration (gavage) of 9 mg Ag/kg bw/day as Ag-NPs or silver acetate (AgAc). The Ag-NPs had 
a size distribution of 14 ± 4 nm in diameter (90% of the NP volume) and were stabilized in aqueous 
suspension by polyvinylpyrrolidone (PVP). Roughly 10% of the total silver content in the Ag-NPs 
suspension was present as silver ions or silver atom clusters. In consequence, the Ag-NPs dosed 
animals were exposed to predominantly Ag-NPs but also in the same dose to a minor fraction of 
silver as ions or clusters. The PVP-stabilised Ag-NPs remained stable throughout the duration of the 
28-day oral toxicity study, which was controlled by repeatedly measuring the distribution of the 
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hydrodynamic size by dynamic light scattering (DLS) over the dosing period. The results showed 
that the organ distribution pattern of silver administered as Ag-NPs or as Ag-acetate (AgAc) were 
similar. The absolute silver concentrations in tissues were however, lower following oral exposure to 
Ag-NPs. This was in agreement with an indication of a higher faecal excretion following 
administration of Ag-NPs. The largest silver concentrations were detected in the intestinal system 
followed by the liver and kidneys. Silver was also found in the lungs and brain. Autometallographic 
(AMG) staining revealed a similar cellular localization of silver in ileum, liver, and kidney tissue in 
rats exposed to Ag-NPs or to AgAc. Using transmission electron microscopy (TEM), nanosized 
granules were detected in the ileum of animals exposed to Ag-NPs or AgAc and were mainly located 
in the basal lamina of the ileal epithelium and in lysosomes of macrophages within the lamina 
propria. Using energy dispersive x-ray spectroscopy (EDX) it was shown that the granules in 
lysosomes of macrophages from rats exposed to Ag-NPs or to AgAc consisted of silver, selenium and 
sulphur. The diameter of the deposited granules was in the same size range as that of the perorally 
administered Ag-NPs. No silver granules were detected by TEM in the liver. 
Conclusion: The results of the study demonstrated absorption of silver from Ag-NPs after oral 
administration to rats. The organ distribution of silver was similar when Ag-NPs or AgAc were 
administered orally but the absolute silver concentrations in the organs were generally lower after 
administration of Ag-NPs than after administration of AgAc in agreement with an indication of a 
higher faecal excretion of silver after administration of Ag-NPs. The presence of granules containing 
silver, selenium and sulphur in the intestinal wall of rats exposed to either of the silver forms 
suggested a common mechanism of their formation. Additional studies are needed to clarify 
whether Ag-NPs dissolve in the gastro-intestinal system and/or become absorbed and translocate 
as intact NPs to organs and tissues.  
In a toxicity study, Sardari 2012 (Sardari et al. 2012) administered suspensions of Ag-NPs of 70 nm 
in diameter in sodium chloride solution using doses of 0, 0.25, 0.5, 1 and 2 mg/kg bw/day by gavage 
to rats (N=10/group) for 30 consecutive days. Following termination, macroscopically and 
histologically changes in the kidneys, liver and spleen from treated rats provided an indirect 
indication of internal exposure to silver following oral dosage with Ag-NP.  
van der Zande et al (van der Zande et al. 2012) reported the results of a 28-day oral exposure study 
in rats exposed to <20 nm non-coated, or <15 nm PVP-coated silver NPs at a dose of 90 mg/kg 
bw/day, or to Ag-ions as silver nitrate (AgNO3) at 9 mg Ag/kg bw/day, or to carrier solution only 
(vehicle control). Sacrifice was performed on day 29. Silver was present in all examined organs and 
its concentration in the tissues was highly correlated to the amount of Ag-ions in the Ag-NP 
suspension. This indicated that mainly Ag-ions, and to much lesser extent AgNPs, passed the 
intestines in the Ag-NP exposed rats. Using single particle ICP-MS, which was used for counting the 
number of NPs, Ag-NPs were detected in silver NP exposed rats, but, remarkably also in AgNO3 
exposed rats. This demonstrated that the formation of NPs from Ag-ions occurred in vivo which 
was in accordance with the findings by Loeschner et al (Loeschner et al. 2011).  
Conclusion: The main target organs for silver distribution upon oral exposure to Ag-NPs or to 
AgNO3 are the liver and spleen, followed by the testis, kidney, brain, and lungs, without any 
difference in the distribution pattern between the PVP-coated and the uncoated Ag-NPs, or the 
AgNO3 exposed animals. When taking only the soluble silver fraction into account, the proportions 
of silver taken up of the Ag < 20 nm and AgNO3 were rather similar. This could indicate that silver 
is mainly absorbed in the ionic form and not in the particulate form after Ag-NP exposure. 
Kim et al (Kim et al. 2009) studied the silver tissue distribution in rats following repeated oral 
administration by gavage of three doses of 60 nm Ag-NPs stabilized with carboxymethylcellulose 
(CMC) against CMC as the vehicle control for 90 days. The doses of Ag-NPs were not reported, but 
were probably 0 (vehicle control), 30, 125 and 500 mg/kg bw/day (see below Kim et al. 2010). The 
tissue distribution of Ag-NPs was investigated using the silver-staining method, which however, is 
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equally reactive to silver as Ag-NPs and as Ag-ions. Therefore, this method did not provide 
information about which form of silver was detected in tissues and organs. Examination of slides 
showed a dose-dependent accumulation of Ag in all the tissues examined, including testes, kidneys, 
liver, brain, lungs, and blood thus providing indirect evidence that silver was absorbed following 
oral administration of Ag-NPs to rats.   
Conclusion: Although the work by Kim et al. suffers from the use of rather non-specific methods 
for detection of Ag and Ag-NPs in the rat tissues, the results demonstrated that silver was detected 
in tissues and organs and thus provided indirect evidence that silver was absorbed following oral 
administration of Ag-NPs to rats. However, it does not contribute to the discussion about the 
chemical form (dissolved or as NPs) in which silver crossed the intestinal wall to enter the blood 
circulation.  
Kim et al. (Kim et al. 2010) published a 90-day study in rats which investigated oral toxicity of 56 
nm Ag-NPs stabilized by carboxymethylcellulose in doses of 0 (vehicle control), 30, 125 and 500 
mg/kg bw/day). Clinical chemistry, hematology, histopathology, and silver distribution were 
studied after the end of clinical phase of the study. Compared to the controls there was a dose-
dependent significant increase in the silver concentration in all tissues from treated rats. The results 
published by Kim et al. in 2010 are apparently the same as published by Kim et al., 2009 (see 
above).  
Groups of mice were exposed orally by gavage to 1 mg/kg bw/day of un-coated Ag-NPs of three 
sizes: 22 nm, 42 nm and 71 nm or to large Ag-NPs (323 nm) for 14 days (Park et al. 2010). Tissues 
for study of the Ag-NPs’ distribution were sampled and digested in HNO3 and H2O2 followed by 
analysis by ICP-MS. Following dosage of the three small sizes of Ag-NPs, silver was distributed to 
brain, lung, liver, kidney, and testis while dosage of the large-sized Ag-NPs (323 nm) did not lead to 
elevated silver concentrations in those tissues. Dose-dependent organ toxicity and inflammatory 
responses correlated with the silver distribution. 
Based on the toxicological findings, the authors concluded that repeated oral administration of Ag-
NPs caused organ toxicity and inflammatory responses in mice and that these effects were size-
dependent.  
Conclusion: The authors of this report concluded that silver from small-sized Ag-NPs (22 nm to 71 
nm) could be more easily absorbed from the gastro-intestinal tract and translocated to the organs 
and exert adverse effects in comparison with their larger counterparts. However, the study does not 
contribute to the discussion about the chemical form (dissolved or as NPs) in which silver crossed 
the intestinal wall to enter the blood circulation. 
Local toxicity of Ag-NPs towards the small intestine was studied in groups of male Swice albino 
mice (Shahare et al. 2013). Ag-NPs ranging from 3-20 nm in diameter were administered orally by 
gavage at a dose of 0 (control) 5, 10, 15, and 20 mg/kg bw/day for 21 days. The small intestine was 
examined by light microscopy and by transmission electron microscopy. Ag-NPs damaged the 
microvilli of the epithelial cells as well as the intestinal glands.  
Conclusion: The authors hypothesized that the local effects of Ag-NPs caused a loss of microvilli, 
which reduced the absorptive capacity of the intestinal epithelium and hence caused body weight 
loss of treated animals. The authors concluded that Ag-NPs destroy the mucosa of small intestine 
and impede its function. However, in what way this affects the absorption of silver from Ag-NPs was 
not investigated. 
3.8.3 In vitro studies 
Two studies were identified. 
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In the only identified study, which employed Caco-2 and M-cells in a co-culture as an in vitro model 
for the human intestinal epithelium, Bouwmeester et al. (Bouwmeester et al. 2011) studied the 
passage of Ag-NPs and Ag+ ions across the cell membrane. The co-cultures were exposed for 4 
hours to four different Ag-NPs which were 20, 34, 61 and 113 nm in diameter and detection was 
carried out by TEM imaging. Exposure to silver ions was included as a control since 6-17% of the 
silver NPs were dissociated to silver ions. The translocation experiments showed that silver dosed as 
Ag-NP suspensions or as AgNO3 (determined by AAS or ICP-MS) can pass the co-culture cell 
barrier and no significant translocation differences between the two types of dosage forms were 
found. An important question was if the nature of the translocated silver was as NPs or as Ag+ ions. 
Because of the procedures used, the analyses did not directly provide information about the form of 
silver in the samples. The amount of silver however, that translocated through the Caco-2 cell 
barrier was equal for the silver ion and NP exposures. The silver ion solution and Ag-NP 
suspensions contained about the same free silver ion concentration and the results showed that the 
amount of silver ions that passed the Caco-2 cell barrier was equal for the silver ion and NP 
exposures.  
Conclusion: This in vitro study indicates that the translocation of silver across the cell membrane 
in this model is likely to occur as Ag+-ions and not as Ag-NPs. 
Gaiser and co-workers (Gaiser et al. 2009) investigated the uptake of Ag-NPs by C3A cells, a human 
hepatocyte cell line, and Caco-2 cells, a human intestinal epithelial cell line. The Ag-NPs were 35 
nm (Ag-NPs) and 0.6-1.6 µm (bulk Ag) in nominal size. The particles were dispersed by sonication 
at 1 mg/ml in culture medium for 15 minutes. 
To assess particle uptake C3A cells plated on glass cover-slips and Caco-2 cells plated on Transwell 
membranes were incubated with media only (negative controls) or particles suspensions at 3.125 
and 31.25 µg/cm2 of Ag of both sizes for 2 hours (C3A) or 24 hours (Caco-2). According to the 
authors of the study both sizes of Ag were taken up into both C3A and Caco-2 cells but data to 
document this statement were not given in the paper. 
Conclusion: This in vitro study was not adequately reported to judge on the potential uptake of 
Ag-NPs in human hepatocytes or enterocytes.  
3.8.4 Synthetic set-ups 
Two studies were identified. 
The fate of Ag-NPs in an in vitro digestion model was studied by Walczak et al (Walczak et al. 2012) 
using 60 nm citrate-stabilized Ag-NPs and silver nitrate as control. The studies were con-ducted in 
two matrices, one without and one in the presence of proteins. The digestive model involved 
consecutive treatments first with artificial saliva as medium for Ag-NPs or AgNO3 as source of Ag+ 
ions. The mixtures were then treated with artificial gastric juice, duodenal juice and finally bile juice 
at 37 oC using mimicked peristaltic movements during incubation. Samples after saliva, gastric and 
intestinal digestion were analysed with single particle-ICPMS (detection of Ag-NPs), DLS and SEM 
with EDX for imaging and elemental analysis and mapping. In presence of proteins and after gastric 
digestion the number of particles dropped significantly, and rose back to original values after the 
intestinal digestion. SEM-EDX revealed that reduction in number of particles was caused by their 
clustering. These NP clusters were composed of silver and chlorine. During intestinal digestion, 
these clusters disintegrated back into single 60 nm Ag-NPs. The authors concluded that these Ag-
NPs under physiological conditions can reach the intestinal wall in their initial size and 
composition. Importantly, intestinal digestion of AgNO3 in presence of proteins also resulted in 
particle formation. These NPs (20–30 nm) were composed of silver, sulphur and chlorine as 
demonstrated by SEM-EDX. The authors concluded that gastro-intestinal digestion impacts Ag-NPs 
and Ag+ ions so that they undergo changes during gastro-intestinal digestion.  
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Conclusion: Orally ingested 60 nm Ag-NPs, digested under physiologically relevant conditions 
(i.e. in the presence of proteins), ultimately can reach the intestinal wall in their size and dispersion. 
Therefore, ingestion of both Ag-NPs and Ag+ ions ultimately leads to intestinal exposure to NPs, 
albeit with a different chemical composition. 
In a similar investigation Rogers et al. (Roger et al. 2012) studied the physico-chemical changes of 
Ag-NPs when exposed to synthetic human stomach fluid (SSF) at pH 1.5 and changes in size, shape, 
zeta potential, hydrodynamic diameter and chemical composition were reported following a 1 hour 
exposure period. The NPs examined included citrate-stabilized Ag-NPs (40 nm nominal diameter) 
and polyacrylate-stabilized Ag-NPs with a 1–10 nm nominal diameter range. Surface plasmon 
resonance (SPR) absorbance, high resolution transmission electron microscopy with energy 
dispersive X-ray spectroscopy (TEM/EDS), dynamic light scattering (DLS), and X-ray powder 
diffraction (XRD) were used to describe the possible changes in Ag-NP characteristics. Exposure of 
Ag-NPs to SSF produced a rapid decrease in the SPR peak at 414 nm characteristic for Ag-NPs in 
the size range of the tested NPs. During exposure to SSF, changes in zeta potential, aggregation and 
morphology of the particles were also observed as well as production of silver chloride which 
appeared physically associated with particle aggregates. The study showed that citrate-stabilized 
Ag-NPs agglomerated and partially reacted to form AgCl during exposure to SSF. Aggregation of 
Ag-NPs seen in this study may influence the production of AgCl.  
Conclusion: Ingested Ag-NPs may be converted to a variety of aggregated and chemically 
modified particles, and in the stomach, the absorption of Ag from the studied Ag-containing 
materials will likely depend on the interactions between this mixture of resulting Ag-containing 
species or particles and the absorptive surfaces of the gastro-intestinal tract. 
3.8.5 Conclusion on the studies concerning systemic absorption of Ag-NPs 
following oral exposure 
There is strong evidence that silver from Ag-NPs become absorbed from the GI tract of 
experimental animals. Several studies describe that following oral exposure by gavage; silver can be 
detected in the blood and is further distributed to organs. Some excretion of silver occurs via faeces. 
The levels in blood and organs are dose-dependent and also depends on the size of the Ag-NPs used 
(i.e. absorption occurs for NPs not larger than 100 nm in diameter). Larger particles however seem 
not to be absorbed to any significant extent. Although distribution studies were meticulously made, 
only few studies touch upon the possible mechanism of the uptake of silver from Ag-NPs and 
addressed the question whether the Ag-NPs were absorbed as the pristine NPs or become absorbed 
following dissolution to low-molecular silver species. A few studies however demonstrated that 
silver-containing NPs were detected by EM imaging in various animal tissues following oral dosage 
with Ag-NPs or following dosage of Ag+ ions. These findings, aided by elemental imaging methods, 
revealed that the silver NPs co-existed with other elements such as selenium and sulphur, or with 
chloride and sulphur for both forms of silver administered via the GI tract. This strongly suggested 
that Ag-NPs were first dissolved and then deposited as insoluble salts in tissues and organelles. 
These findings are further supported by research in vitro using cell lines or synthetic set-ups, which 
generally conclude that the trans-membrane passage or release into synthetic digestive solutions 
occurs equally efficient for Ag-NPs as for Ag+ ions. This suggests that Ag-NPs dissolve in the GI 
tract prior to absorption from the small intestine, to enter circulation and subsequently reach 
primarily the liver and spleen and to a lesser degree other organs. A few papers investigated and 
compared Ag-NPs with different polymeric coatings/stabilizers, but were unable to find any 
difference in their fate in the GI tract or in their deposition in the animals’ organs.  
3.8.6 Identification of gaps in current knowledge and future research needs in 
relation to Ag-NPs 
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In order to better predict the possible oral absorption of Ag-NPs, more knowledge is needed about 
the interaction between Ag-NPs and various co-digested food items or types of food. Information 
about the influence of food components on the absorption rate of small, intact Ag-NPs (1-20 nm) or 
following dissolution as Ag+ ions is missing. Furthermore, future research using Ag-NPs that have 
been specifically synthesized with a covalently bound outer layer of negatively or positively charged 
or electrically neutral moieties will be useful for improving our understanding about absorption of 
Ag-NPs with a well-defined chemical “interface” to the biological surroundings. As far as analytical 
methodology is concerned, development of easy-to-use methods for determining the NPs’ number-
size distribution is important bearing in mind the European Commission’s recommended definition 
from 2011 of NPs, i.e. a distribution of particles, for which at least 50% of the number of particles is 
below 100 nm in diameter.  
 
3.9 Titanium dioxide 
3.9.1 Usage  
Titanium dioxide (TiO2), is a high-production volume chemical (i.e. produced in more than 1000 
tons/year) mainly used as a pigment in its bulk form. It is the most widely used white pigment in 
paints, paper, plastic, coatings, ceramics, inks, pharmaceuticals, cosmetics, toothpastes and food. 
While TiO2 rank as one of the most used chemicals world-wide (mainly as a pigment), the tonnages 
of nanometre sized TiO2 used nationally, in the EU or worldwide can at present not be estimated. 
This is due to the fact that no specific inventories for nanomaterials exist. However, it should be 
mentioned, that in some consumer products, e.g. sunscreens, the percentage of nanoparticulate 
TiO2 (TiO2-NPs) may constitute several per cent of the product (Hansen et al 2008). TiO2 used as 
food additive (E 171), may also contain a fraction of TiO2-NPs, and it is used for whitening and 
brightening of food, especially for confectionary, white sauces and dressings and certain powdered 
foods. It has been estimated, that in UK the dietary intake of TiO2 (non-nano + nano) is 5 
mg/person per day (Powell et al, 2010). Given the range of possible applications of TiO2-NPs 
especially within photo-catalysis (e.g. for self-cleaning surfaces and water treatment), the use of 
TiO2-NPs is anticipated to increase significantly in the near future. It should also be noted that the 
food products with the highest content of TiO2 are sweets including chewing gums and it has been 
estimated that children may have the highest exposure to TiO2 (Weir as cited in (Wang et al. 2012)). 
A number of different crystal structures of TiO2 exist of which the rutile and anatase forms of TiO2 
are the most important in relation to the use of TiO2 in consumer products. Both crystal structures 
are approved food colours (EFSA 2004). 
3.9.2 In vivo studies 
Four studies were identified. 
In a study by Wang et al 2012 (Wang and Fu 2012) the distribution of TiO2-NPs was investigated in 
young (3 weeks old) and adult (8 weeks old) male Sprague-Dawley rats. The TiO2-NPs were 
dispersed in ultrapure water and ultrasonicated and stirred before use. The intragastric doses were 
selected based on the estimated dietary intake of TiO2 particles in the UK which has been estimated 
to be about 5 mg/person/day, equivalent to approximately 0.1 mg/kg bw/day. In this study, a dose 
100 times higher (10 mg/kg bw/day) than the potential human exposure, was used as the low-dose 
TiO2-NP exposure in rats. The young and adult rats (7 per group) were administrated 0, 10, 50 or 
200 mg/kg bw/day of TiO2-NP by gavage, once a day for 30 consecutive days.   
The nanomaterial was well characterized in its solid form (i.e. as the powder). It was shown by TEM 
analysis that the TiO2-NPs were nearly spherical anatase crystals with hydroxyl groups on the 
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surface. The purity was 99.9%. The average size of the TiO2-NPs was 75 ± 15 nm and the measured 
Brunauer–Emmett–Teller (BET) specific surface area of the TiO2-NPs was 63.95 m2/g.  
In order to better understand the characteristics of NPs in the exposure medium and the rat gastro-
intestinal tract, the hydrodynamic diameter and Zeta potential of TiO2-NPs in ultrapure water, 
artificial gastric juice (AGJ) and artificial intestinal juice (AIJ) were tested. It was clear that the 
TiO2-NPs were converted into larger particles in water, AGJ and AIJ, which is likely due to particle 
aggregation. The largest particles (hydrodynamic diameter) were found in AIJ (2081 nm) followed 
by AGJ (1702 nm) and water (474 nm). 
Blood, liver, kidney and spleen from the highest dose group were analyzed for elemental titanium 
(Ti) content by ICP-MS. The liver and the mucosa of the stomach and small intestine were dissected 
into small pieces and analyzed by TEM.  
The TEM images clearly showed that some particles with a diameter of approximately 60–200 nm 
adhered to the intestinal villi and absorbed in the stomach and small intestine tissue. However, no 
particles were found in the liver of young and adult rats. The contents of titanium in the blood, liver, 
kidney and spleen of young and adult rats in the TiO2-NPs treated groups were not significantly 
different from the control group after oral exposure. This indicated a very low absorption of TiO2-
NPs from the GI tract and that the NPs located in the mucosa of the stomach and small intestine did 
not translocate into the systemic circulation.   
It is generally agreed that absorption of NPs by the oral route increases with decreasing particle 
diameter. Based on the large hydrodynamic sizes of TiO2-NPs in artificial gastric juice (AGJ) and 
artificial intestinal juice (AIJ), the TiO2-NPs quickly aggregated into larger particles (1702 ∼ 2081 
nm) in the gastro-intestinal tract, which may contribute to the low absorption and translocation 
rates.  
Conclusion: Based on this 30 days study it can be concluded that the absorption of anataseTiO2-
NPs at a dose up to 200 mg/kg bw seems to be low, which may be due to aggregation of the NPs to 
larger particles in the GI tract. The highest dose in this experiment was 2000 times higher than the 
potential human exposure by the oral route (0.1 mg/kg bw/day).  
Onischenko 2012 (Onischenko et al. 2012) investigated the penetration of titanium dioxide NPs into 
enterocytes after their administration into isolated loops of rat small intestine in an in situ 
experiment. In a separate 28 days study they investigated the absorption and distribution of TiO2-
NPs in rats. 
Four male Wistar rats were used for the in situ experiment. The ileac loop (4-5 cm long) was 
exposed under aseptic conditions through a small incision in the abdominal wall. The loop was 
carefully isolated with silk ligatures without impairing the mesenteric vessels, and rutile TiO2-NP 
dispersion (50 mg/cm3) in isotonic salt solution was injected into the intestinal loop distally from 
the lower ligature. The ligatures were tightened, the abdominal wall and the skin were sutured, and 
the rats were placed in cages for 3hours until time of sacrifice. 
In the 28 days study 4 male rats per group received a low dose (1 mg/kg bw/day) and a high dose 
(100 mg/kg bw/day) of water suspensions of either anatase TiO2-NPs, rutile TiO2-NPs or micron 
size TiO2 particles (the food additive E 171). The rats were dosed daily for 28 days by gavage.  
The particle size and shape was measured by TEM. The anatase particles were spherical or elliptic 
with a diameter of 20-25 nm and the rutile form had a diameter of 5-10 nm and a length of 40-50 
nm.  
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The physico-chemical nature of NP detected in the intestinal epithelium was studied also by 
spectroscopy of characteristic loss of electron energy (SCLEE). The authors emphasized that this 
method could be properly used only for analysis of NP aggregates, but this finding is not explained 
in any further detail. 
In the in situ study penetration of TiO2-NPs into enterocytes after their administration into the 
isolated loop of rat’s small intestine was shown in vivo by transmission electron microscopy. Using 
electron diffraction, TiO2-NPs were identified in the apical regions of the cells under the plasma 
membranes and in the deeper parts of the cytoplasm as solitary objects or small aggregations (100-
150 nm). In this study it was demonstrated, that at least part of TiO2-NPs present in the intestinal 
lumen and located on the surfaces of microvilli and individual TiO2-NPs present in the enterocyte 
apical part and in the cytoplasm had crystal structure. Water dispersions of NPs (3 hour exposure to 
high concentrations) caused no appreciable morphological changes in enterocyte ultrastructure.  
In the 28 days study, the content of titanium was measured in the liver. After 28 days 
administration of water dispersions of TiO2-NPs with anatase structure and micron sized particles 
no increase in the base level of titanium in the liver was observed either after low dose (1 mg/kg 
bw/day) or high dose (100 mg/kg bw/day) exposure. A similar result was observed in animals 
treated with rutile TiO2-NPs in the low dose group (1 mg/kg). However, titanium concentrations in 
the liver, determined by ICPMS increased by about a factor of two in rats given rutile TiO2-NPs 
water dispersion at the high dose (100 mg/kg). This could indicate the penetration of TiO2-NPs 
through the intestinal barrier, which might also be indicated by the in situ study described above. 
However, it is not known whether the systemic exposure to titanium occurs in the form of NPs or as 
dissociated titanium, or both.  
Conclusion: This study, which was performed under “near physiological conditions” indicated 
that TiO2-NPs are more readily absorbed than microsized particles (E 171), and the absorption is 
also dependent of the crystalinity of the particles, with the rutile form being the most well absorbed. 
However, titanium could only be detected in the liver after exposure to doses 1000 times higher 
than the expected human exposure. 
The distribution of TiO2-NPs (25 and 80 nm) and fine TiO2 (155 nm) particles in CD-1 mice was 
investigated by Wang et al. (Wang et al. 2007). The particles were suspended in 0.5% hydroxypro-
pylmethylcellulose (0.5% HPMC). The suspensions were ultrasonicated and mechanically vibrated 
before administration to the animals. Due to its low acute toxicity a single large dose of 5 g/kg bw of 
TiO2 particle suspensions was administered by a single oral gavage. Ten males and 10 females pr. 
group were dosed with 0.5% HPMC (control), 25 and 80 nm TiO2-NPs or large (“fine”) TiO2-NPs 
(155 nm). Histopatological tests were performed using standard test procedures. Two weeks after 
dosing the animals were sacrificed and blood and tissue samples were taken from heart, liver, 
spleen, kidneys, lung, brain testis or ovary. 
The particle size (at pristine stage and in suspension) was measured by TEM. The tissues were 
measured for total titanium content by ICP-MS, but not for the presence of particles. 
Two weeks after exposure to an extremely high dose of TiO2-NPs no obvious acute toxicity was 
observed. Accumulation of titanium was observed in female animals in their kidneys, spleen, and 
lung after exposure to all three types of particles. For the 80 nm TiO2-NPs group, high 
concentration of titanium was measured in the liver tissue (3970.4±1670.1 ng/g), whereas the 
titanium content was 106.3±7.8 ng/g in the 25 nm TiO2-NP group and 106.7±25.1 ng/g in the fine 
TiO2 group, which was not significantly different from the control group. In the kidneys, the 
titanium concentrations in the 80 and 25 nm TiO2-NPs groups were significantly higher than those 
in the control and fine TiO2 groups (p < 0.05). 
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Conclusion: This study gives some indication that TiO2-NPs are absorbed from the gastro-
intestinal tract after oral exposure to extremely high doses. From this study it is not clear in which 
form TiO2 is absorbed (ions, particles or both). Furthermore, it is not clear whether absorption is 
size dependent because the tissue concentrations resulting from dosage of the two nano-sized 
suspensions appeared to be contradictory (high tissue Ti for larger TiO2-NPs). The authors do not 
provide any detailed information about the size distribution of the TiO2-NPs in the two suspensions 
immediately prior to administration. A hypothetical explanation could be that aggregation of the 
pristine NPs has occurred and therefore influence the intestinal uptake. Two weeks after exposure 
accumulation was observed in the liver, but it is unclear why only the 80 nm and not the 25 nm and 
fine particles accumulate. Accumulation was also observed in the kidneys of 25 and 80 nm particles 
but not “fine” particles (155 nm). It is not mentioned which crystal structure was investigated.  
In a study by Jani et al. (Jani et al. 1994) the uptake of rutile TiO2 particles from the rat’s gastro-
intestinal tract and translocation to systemic organs after oral administration were investigated. 
Although the size of TiO2 particles were not strictly in the nanometre sized, but in the size range of 
475 ± 24 nm, this study was considered because it was well performed and gave some important 
information on the absorption and distribution of TiO2 rutile particles to different tissues.  
Rutile TiO2 particles of nominal size 500 nm suspended in water were administered at a dose of 
12.5 mg/kg bw to female Sprague Dawley rats, by oral gavage daily for 10 days. Size analysis by 
dynamic light scattering confirmed that the hydrodynamic size (in aqueous suspension) was close to 
the nominal size of 500 nm in diameter. Organs and tissues such as Peyer's patches, small intestine, 
colon, mesentery network and nodes, peritoneal tissue, liver, spleen, heart and kidney were 
removed for histology, scanning electron microscopy, and spectroscopic analysis for titanium, using 
inductively coupled plasma atomic emission spectroscopy. Histological examination showed the 
presence of titanium dioxide particles in all the major lymphoid tissue associated with the gut 
(GALT), and demonstrated that 500 nm titanium dioxide particles were translocated to systemic 
organs mainly the liver and to a lesser extent the spleen. It was demonstrated, that particle uptake 
in the gastro-intestinal tract takes place principally via Peyer’s patches, rich in lymphatic supply and 
phagocytic cells; the particles were then translocated to the mesentery network, and accumulate in 
the mesentery nodes. Some particles may then enter the general circulation and were taken up by 
the liver and the spleen. Four per cent of the administered dose was found in the colon, 2.86% in 
Peyer’s patches the mesentery network and nodes and 1.4% in the liver. It was calculated that 
absorption of 6.5% of the total dose of titanium dioxide particles in the 500 nm size range 
administered orally over 10 days takes place.  
Conclusion: In this study, there are indications that a minor part of the rutile form of titanium 
dioxide was absorbed and distributed to some organs in its particulate form after oral exposure 
even though the administered TiO2 particles were not in the nanometre size range.  
3.9.3 In vitro studies 
One study was identified. Koeneman et al. (Koeneman et al. 2010) studied three different pathways 
for uptake of TiO2-NPs in an in vitro model using the human derived Caco-2 cell line, which in 
culture can mimic the epithelial cell layer of the gastro-intestinal tract. A commercially available 
suspension of TiO2-NPs in water was used. The particle diameter as provided by the manufacturer 
was < 40 nm. The mean particle sizes and size distributions of nanomaterials suspended in water 
and DMEM medium (Dulbecco’s Modification of Eagle’s Medium) were analysed by dynamic light 
scattering DLS by the authors to be 220 ± 20 nm in water and > 500 nm in DMEM medium.  
Z-average diameters of the nanomaterials in nanopure water (220 nm) were much larger than the 
values provided by the manufacturer. From particle size distributions, it was observed that the 
TiO2-NPs were within the size range of 80 to 350 nm. However, compared with nanopure water, 
DMEM medium led to the further aggregation of nanomaterials up to 500 nm. The Z-average 
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diameters of nanomaterials also increased rapidly with time. TiO2 was imaged inside the cells by 
measuring reflection of a HeNe laser by scanning confocal microscopy. 
The study provided evidence that TiO2-NPs cross the epithelial lining of the intestinal model at low 
levels after concentrations at 10 µg/ml and above. Three possible mechanisms by which the 
nanomaterials could potentially cross an epithelial layer were investigated: (1) by disrupting the 
junctional complexes without killing cells in the epithelial sheet, (2) by killing cells within the 
epithelial sheet thereby forming holes in the epithelial sheet and (3) by using the transport function 
of epithelial cells, used by nutrient, and pass through individual epithelial cells by transcytosis. 
After investigation into these three pathways, pathway 1 was not considered likely because after 
exposure to TiO2 the junctional complexes remained intact, except at 1000 μg/mL (a concentration 
not likely to be encountered). Pathway 2 was also considered unlikely based on the transepithelial 
electrical resistance (TEER) measurements, the undisturbed pattern of junctional proteins, and the 
results of the live/dead assays which indicated that the cells remain alive after both acute and 
chronic exposure to TiO2. Pathway 3 appeared to occur because TiO2-NPs were found both in the 
cells and underneath the cells without disrupting the junctional complexes or killing the cells. 
Conclusion: This study indicated that TiO2-NPs can cross the epithelial lining of the gastro-
intestinal tract at low levels by transcytosis after exposure to concentrations of 10 µg/ml and above. 
3.9.4 Synthetic set-ups 
No relevant studies were identified. 
3.9.5 Conclusion on the studies concerning systemic absorption of titanium 
dioxide following oral exposure 
Although TiO2 is one of the most widely used chemicals in the world only few studies exists on the 
absorption after oral exposure.   
An in vitro study indicates that TiO2-NPs as such can cross the epithelial lining of the gastro-
intestinal tract at low levels by transcytosis after exposure to concentrations of 10 µg/ml and above. 
Three in vivo studies on absorption of the nanoform were identified. For comparison also one study 
on absorption of the bulk form is described in this report. Based on these studies it can be 
concluded that the absorption of TiO2 particles is low and only around 6% for the bulk form. It is 
not possible to estimate the absorbed amount of TiO2-NPs, but there is some indication that at 
“near physicological” doses of the anatase form of TiO2-NP (up to 200 mg/kg bw/day) no TiO2-NPs 
could be detected in blood or liver, kidney and spleen (in general the most relevant organs for 
accumulation of NPs). Only at extremely high exposure (5 g/kg bw) accumulation was observed in 
liver, kidneys, spleen and lung. However, it is not possible to evaluate the degree of absorption 
based on this study, and it is also not possible to conclude whether the absorbed TiO2 occurred as 
ions, particles or a combination. Finally, in most of the studies, TiO2 agglomeration was often seen 
in the suspensions administered to the animals. It therefore remains a question which size 
distribution the experimental animals were actually exposed to. 
3.9.6 Evaluation of factors influencing systemic absorption of titanium dioxide 
following oral exposure 
It is generally agreed that absorption of nanomaterials increases with decreasing particle size. 
However, this is not entirely clear from the available studies on TiO2; but there is some indication 
that agglomeration of the anatase form could explain the low absorption of these particles. Only one 
study addressed the influence of crystal structure of NPs on absorption after oral exposure. The 
result from this study indicated that the rutile form is better absorbed than the anatase form. This is 
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remarkable bearing in mind that the anatase form is regarded as the most toxic (Mikkelsen et al. 
2011). 
3.9.7 Identification of gaps in current knowledge and future research needs in 
relation to titanium dioxide 
There are very few well performed in vivo studies on the absorption of TiO2-NPs. There remains a 
need for studies, which can explain whether these NPs are absorbed as ions, particles or a 
combination of both. There is also a need for studies showing the amount and rate of absorption at 
physiological conditions and the influence of size, crystal structure and surface treatment.  
 
3.10 Zinc oxide 
3.10.1 Usage  
Zinc oxide (ZnO) is a very commonly used metal oxide and has traditionally been used in paints, 
pharmaceuticals and ceramics. During recent years engineered ZnO nanoparticles (ZnO-NPs) have 
been used in sunscreen cosmetics, dental composites, and dermal ointments. ZnO-NPs have 
antibacterial activity, which is size dependent and might involve reactive oxygen species (ROS) (Li 
et al. 2008). Due to its good absorptive and photo catalytic properties ZnO-NPs can also be used in 
environmental remediation for elimination or degradation of pollutants in water or air (Wang et al. 
2008). 
3.10.2 In vivo studies 
Five relevant in vivo studies on absorption after oral exposure were identified and are summarized 
below. 
The key study was a study by Baek et al. (Baek et al. 2012). This study explored the 
pharmacokinetics of ZnO-NPs of two different sizes (20 and 70 nm) after oral administration to 
male and female rats. The nano-particles were coated with citrate by suspension in 20 mM HEPES 
buffer containing 1% sodium citrate and dispersed by vortexing for 1 minute. Each type of ZnO-NPs 
was given to three groups of male and female rats (6 per group) as a single oral dose of 50, 300 or 
2000 mg/kg bw by gavage. The control group (3♀ and 3♂) received an equivalent volume of 
citrate/HEPES buffer. Blood samples were taken from the tail vein at the following time points: 
time zero and 0.5, 1, 2, 4, 6, 10, 24, 48, 72 and 96 hours after the administration. Samples of the 
brain, heart, kidney, lung and testis or ovary were taken 1 and 6 hours and 1, 2, 3 and 7 days after 
the administration.  
The citrate modified NPs had a negative surface charge (-28.1 mV for 20 nm and -33.3 mv for the 70 
nm size). The average diameters were measured by SEM and TEM to be 21 ± 6 nm and 71 ± 19 nm, 
respectively. The total zinc content was measured in the organs by ICP-AES. 
In addition, liver, kidney and spleen samples were collected from 3 male rats 24 hours after 
administration of 2000 mg/kg bw of the two different sizes of ZnO-NPs. Three male rats treated 
with citrate/HEPES buffer were used as controls. TEM and XAS analysis were performed on the 
organs. 
The plasma zinc concentration increased during the first 24 hours after administration of both sizes 
of ZnO-NPs in a dose dependent manner. Zinc was mainly distributed to liver, lung and kidney 
within 72 hours. No significant differences were observed related to size of particles or gender of 
rats.  
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The estimated rate of absorption was dose dependent (5-17% at the low dose and 28-33% at the 
high dose). The absorption was slightly higher for the small particles than the larger ones. 
According to the TEM and XAS studies of the tissues, ZnO-NPs appeared to be distributed into 
organs in the form of zinc ions rather than as ZnO particles as demonstrated by the observation of 
zinc sulphide bonds in the tissues. After 7 days, less than 0.1% of the ingested Zn was retained in the 
analyzed organs. 
Only a minor amount of the ZnO was cleared via the urine (1.32 – 1.47% of the administered dose), 
while most was excreted via the faeces. The excretion rate via urine decreased when the dose was 
increased, while the excretion via the faeces increases in a dose dependent manner. 
Conclusion: Only a minor amount of orally administered ZnO-NPs is absorbed and there is strong 
indication that the distribution to different organs occurs as ions. Zinc in mainly distributed to the 
liver, lung and kidney, and most of the administered dose is cleared within 7 days mainly in the 
faeces, indicating that ZnO-NPs do not accumulate. The uptake of zinc following dosage of smaller 
ZnO-NPs is slightly higher than from dosage of larger ones. 
Li et al. (Li et al. 2012) investigated the distribution and elimination of zinc from ZnO-NPs 
following a single oral gavage dose of ZnO-NPs with a particle diameter of approximately 50 nm 
and ZnO micro particles (ZnO-MPs) with at least one external dimension > 100 nm as a reference 
control. Male ICR mice (10-12 per group) were administered a single oral dose of either vehicle 
(control group), 2.5 g/kg bw ZnO-NPs suspension or 2.5 g/kg bw ZnO-MP suspension. The NP’s 
morphology, size and agglomeration were characterized by transmission electron microscopy 
(TEM), and dynamic light scattering (DLS) was used for particle size analysis. Some agglomeration 
was observed in the dosing suspension of ZnO-NPs but the primary particles were dominant.  
DLS showed an average hydrodynamic diameter of the ZnO-NPs of 93.35 ± 14.53 nm and for ZnO-
MPs 1226.2 ± 120.4 nm. The ZnO particles were suspended in DMSO, diluted by sterile water and 
1% hydroxypropyl methyl cellulose (HPMC) was used as stabilizing agent. The Zn-NPs or Zn-MPs 
were administered to the animals immediately after preparation. Zinc levels in the serum were 
measured by ICP-MS. 
Blood samples were collected from at least three mice from each group at 0.5, 1, 2, 4, 6, 24, 48 and 
72 hours post dosing. Test mice were sacrificed 24, 48 and 72 hours post dosing. Gross necropsy 
and tissue sampling were performed (heart, kidney, liver, lung, spleen testes and brain).  
This study showed that the maximum absorption occurred at 2 hours for both NPs and MPs of ZnO. 
Within the first 2-6 hours of the testing period the mean serum zinc levels were significantly higher 
in the ZnO-NPs dosed groups than in the ZnO-MP groups. These data indicate that ZnO-NPs are 
more efficient absorbed than ZnO-MPs.  
The investigation of the distribution showed, that there was no increase in the zinc levels com-pared 
to the controls in the lung, brain and testes. However, in the liver, spleen and kidney the zinc levels 
were increased over the period from 24 to 72 hours and more obviously for ZnO-NPs than for ZnO-
MPs suggesting a more efficient particle distribution concentration in these organs for NPs than for 
microparticles, or a higher blood concentration of ZnO-NPs (or dissolved Zn) than of ZnO-MPs.  
In order to investigate whether the higher degree of absorption of ZnO-NPs were due to dissolution 
to zinc ions a dissolution study was performed with NPs, MPs and ZnCl2. The degree of zinc ion 
release was not significantly different between ZnO-NPs and ZnO-MPs which led the authors to 
suggest that the observed difference in absorption and tissue levels of zinc in this study was due to 
particle size. 
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Histopatological changes in the liver were observed 48 hours post gavage in ZnO-NPs treated mice 
(affected group(s) not stated) but not in ZnO-MP treated and control mice.  
Conclusion: It is likely that absorption, distribution and toxicity to target organs of ZnO depended 
on the size of the particles and that ZnO-NPs were more efficiently absorbed than the larger ones. 
The distribution occurred mainly in the liver, spleen and kidney. The very high, but unrealistic, 
doses and the lack of attempt to characterize the presence of NPs in the tissues or blood render this 
conclusion of questionable value, and more detailed studies are warranted. 
In a study by Wang et al. (Wang et al. 2008) the acute oral toxicity of 20 and 120 nm ZnO NPs was 
investigated. This dose and size effect study was performed in CD-ICR mice, (5 males and five 
females/ group). The ZnO particles were suspended in 1% sodium carboxy methyl cellulose used as 
stabilizer. The mice were administered a single dose of 1, 2, 3, 4 and 5 g/kg bw by gavage of either 
20 nm or 120 nm ZnO particles in suspension. The control group received 1% sodium carboxy 
methyl cellulose. The animals we sacrificed 2 weeks after the start of the experiment. Blood was 
obtained from optical veins, and the following organs were collected: liver, heart, spleen, stomach, 
kidneys, pancreas, testis or uterus and brain. 
The size distribution in the administered ZnO NP suspension was determined by light scattering. 
The particle sizes of 20 and 120 nm ZnO in the administration solutions were about 44.8 ± 16 nm 
and 187 ± 1.3 nm, respectively. The dissolution rate of ZnO NPs in artificial gastric fluid was 
determined and was slightly higher (0.021%/min) for 20 nm than for 120 nm (0.016%/min) ZnO 
NPs.   
The concentration of Zn in serum, organs and tissues of mice exposed to ZnO-NPs at the highest 
dose (5 g/kg bw) was measured, and compared to controls. A significantly higher concentration was 
found in the kidney, pancreas and bone (p<0.05) and a slight increase was found in the liver and 
heart of ZnO treated mice (p>0.05). The Zn concentrations in the liver, kidney and pancreas were 
slightly higher for mice administered the 20 nm than the 120 nm ZnO-NPs, indicating that more Zn 
was absorbed and distributed to these organs from 20 nm ZnO than from 120 nm ZnO-NPs. The 
highest concentration was found in bone and the 120 nm dosed mice retained significantly higher 
Zn levels in the bone than the 20 nm dosed mice. This is in accordance with the observation, that 
bone is a “reservoir” for dietary Zn (Sandoval et al. 1999 in Wang 2008).  
Conclusion: The target organs for distribution of 20 and 120 nm ZnO NPs were liver, heart, 
spleen, pancreas and bone. From this study it is not possible to conclude whether ZnO-NPs were 
absorbed as ions or as particles, or both.  
In a study by Lee et al. (Lee et al. 2012a) the behaviour and accumulation of nanoscale and 
submicron-scale zinc oxide (ZnO) particles in the body was investigated using real-time optical 
imaging based on fluorophor-labelled ZnO-NPs with a nominal size of 20 nm and 100 nm. The size 
distribution determined by DLS was 25.4 ± 3.9 nm for the 20 nm size and 78.9 ± 13.4 for the 100 
nm size, respectively.  
Sprague-Dawley rats (sex and number per group not given) were given by gavage 250 mg/kg bw of 
the labelled ZnO-NPs (Cy5.5 conjugated ZnO-NPs), either 20 nm or 100 nm in diameter, and the 
control group received 0.5 mg/kg bw of the fluorescent dye Cy5.5NHS. The labelled ZnO-NPs were 
stable in simulated gastric fluid for 7 hours. Blood samples were obtained at preselected time points 
after the administration for optical image studies and in vivo optical images of rats from the 2 
dosage groups and the control group were performed after 1, 2, 3, 5 and 7 hours. The animals were 
sacrificed 23 hours after the administration and ex vivo optical images of the heart, lung, liver, 
spleen, pancreas, kidney, muscle and bone were performed. The fluorescent dye Cy5.5NHS showed 
the strongest optical signal intensity in the blood samples at 3 hours after oral administration, and 
the signal intensity decreased after that time. The highest signal intensity in rat blood was shown 5-
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7 hours after the administration of the labelled ZnO-NPs, showing that ZnO-NPs of both sizes were 
absorbed with a higher absorption rate for the smaller particles compared to the bigger ones.  
Whole rat body optical fluorescence images were also performed showing that nanoscaled ZnO 
particles moved more rapidly into the gastro-intestinal tract from the stomach than the submicron-
scaled ZnO, which remained for a longer time in the stomach. Ex vivo images of different organs 
demonstrated that ZnO-NPs were distributed mainly to the liver and kidney, with the highest 
signals in the kidneys. There were no significant differences in the signals in the other organs 
between nano- and submicron-scaled NPs.  
Conclusion: Optical imaging can be used to follow the movement of NPs after oral absorption, but 
cannot be used to investigate the amount of absorbed material or in which form it is absorbed.  
In a similar study Lee et al. (Lee et al. 2012b) investigated the behaviour and accumulation of nano-
scaled ZnO (20 nm) and submicro-scaled ZnO (100 nm) particles in organic tissues after oral 
administration using PET imaging in female BALB/c mice after administration of a single oral 
gavage dose of 100 mg/kg bw. Both types of ZnO NP (20 or 100 nm) were labelled with the 
radionuclide 18F in high yield via ‘click reaction’. 18F labelling on the ZnO-NPs was shown to be 
maintained stably in simulated gastric fluid (pH 1.2) for 7 hours. Three hours after the 
administration, PET images indicated that the radioactivity for 18F-labeled ZnO NPs was seen only 
in the gastro-intestinal (GI) tract. At 5 hours post-administration, the brain, heart, lung, liver, 
pancreas, spleen, kidney, bone, and muscle, were removed from the mice and ex vivo PET/CT 
imaging was performed. The study using 18F-labeled ZnO-NPs showed radioactivity in the lung, 
liver and kidney including the GI tract. Submicro-scaled 18F-labeled ZnO-NPs (100 nm) showed 
stronger radioactivity in the liver and kidney compared to the nano-scaled 18F-labeled ZnO-NPs (20 
nm). 
Conclusion: PET imaging has the potential to monitor and evaluate the behaviour of ZnO-NPs 
absorbed in organic tissues following oral exposures, but cannot be used to investigate the amount 
of absorbed material or in which form it was absorbed.   
3.10.3 In vitro studies 
No relevant in vitro studies were identified for ZnO-NPs. 
3.10.4 Synthetic set-ups 
No relevant studies were identified. 
3.10.5 Conclusion on the studies concerning systemic absorption of zinc oxide 
following oral exposure 
The absorption rate of zinc from ZnO NPs is dose dependent (5-33% depending on the dose), and to 
a lesser extent also size dependent. The absorption is slightly higher for the small particles 
compared to the larger ones. In most studies zinc was measured and was mainly distributed to liver 
and kidney but was also measured in lung, pancreas and bone in other studies. From one well 
performed study there is strong indications that zinc from ZnO-NPs were distributed to the organs 
in the form of Zn-ions rather than as ZnO-NPs because Zn-S bonds and not Zn-Zn bonds were 
observed in the tissues where Zn was deposited. ZnO-NPs were mainly excreted via the faeces. Only 
a minor amount of zinc was retained in the analysed organs indicating that zinc and ZnO-NPs do 
not accumulate.   
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3.10.6 Evaluation of factors influencing systemic absorption of zinc oxide 
following oral exposure 
In the available studies on ZnO-NPs the only physical chemical characteristic that was investigated 
was a difference in size. As described above the absorption of zinc is slightly higher for the small 
particles compared to the larger ones, which could be due to a higher dissolution rate of smaller 
particles compared to their larger counterparts.  
3.10.7 Identification of gaps in current knowledge and future research needs in 
relation to zinc oxide 
Only one study was identified where the requirements in EFSAs guideline on characterization of the 
ENMs in biological fluids and tissues. This study indicates that absorbed ZnO-NPs 
dissolves/degrades in the gastro-intestinal tract without absorption of the pristine NPs. The hazard 
identification and hazard characterisation can therefore rely on data for the non-nanoform sub-
stance (if available). However, more studies are needed to confirm whether the intact ZnO-NPs 
indeed are taken up only in the dissolved state or whether a fraction of ZnO (defined by size, surface 
coating and stabiliser) may reach the target tissues as the intact NPs. 
If ZnO-NPs are used in food or consumer products with other modifications than those reported 
(e.g. different coatings, or surface charges), studies on these modified particles need to be 
performed for acquisition of information on the absorption rate of such a broader range of ZnO-NPs 
modifications.  
 
3.11 Phase II.1  Evaluation of physical and chemical properties expected 
to influence absorption of nanomaterials 
It is generally agreed that the nanomaterials’ physico-chemical characteristics like size, shape, 
solubility, crystallinity (crystal structure), coatings/stabilizers, surface charge and surface reactivity 
can influence their absorption. However, in the studies presented in the present review very few of 
these parameters were thoroughly investigated or documented. In each of the chapters on the 
different nanomaterials there is a summary of which physical and chemical properties that had 
been investigated and which may influence the absorption of that substance. A short summary for 
all materials is given below. 
For the following substances no evaluation of factors influencing their systemic absorption 
following oral exposure can be given due to lack of data: CNTs, CeO2, fullerenes, SiO2-NPs and Se-
NPs. 
It is well known that the size of nanomaterials has an influence on their absorption rate, and that 
absorption of nanomaterials increases with decreasing particle size. This trend was indeed 
demonstrated for iron oxide, where the results by Singh and co-workers (Singh et al. 2013) 
indicated that the oral absorption of iron was higher for nanoparticulate material compared to bulk 
material.  
The uptake of Au-NPs from the gastro-intestinal tract was also size dependent. Smaller particles (4 
and 10 nm) crossed the gastro-intestinal tract more readily than did the tested 28 and 58 nm 
particles.  
For Ag-NPs the absorption also depends of the size, and it was demonstrated that absorption occurs 
for NPs up to 100 nm in diameter. It should be noted however, that the apparent higher absorption 
rate for the smaller Ag-NPs may be under the influence of higher degree of dissolution as Ag-ions or 
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as Ag atomic clusters causing a higher Ag concentration in tissues and organs. Larger particles 
however seem not to be absorbed to any significant extent. 
For TiO2-NPs is not so clear from the available studies whether the absorption from the gastro-
intestinal tract is size dependent. There is however, some indication that agglomeration of the 
anatase crystal form could explain the low absorption of nanoparticles based on this crystal form 
The absorption of ZnO-NPs is slightly higher for the small particles compared to the larger ones, 
which could be due to a higher dissolution rate of smaller particles compared to their larger 
counterparts. 
A few papers investigated and compared Ag-NPs with different polymeric coatings used as 
stabilizers, but any difference in their fate in the gastro-intestinal tract was not demonstrated. 
Only one study addresses the influence of crystal structure of NPs on absorption after oral exposure. 
The result from this study indicates that the rutile form of TiO2 is better absorbed than the anatase 
form. 
Table4 gives an overview of the different physical and chemical properties which may influence the 
absorption of nanoparticles. 
TABLE 4 OVERVIEW OF IDENTIFIED PHYSICAL AND CHEMICAL PROPERTIES WHICH INFLUENCE THE 
ABSORPTION OF NANOMATERIALS 
Nanomaterial Absorption Absorption as 
ions or as NPs 
Investigated 
factors  
Influence of factor 
Carbon 
nanotubes 
No relevant 
oral 
absorption 
studies. 
Indication of 
very low 
absorption 
Not investigated None Not investigated 
Cerium  Yes  None Not investigated 
Fullerene Limited 
absorption 
 None Not investigated 
Gold Yes  Size Higher absorption of 
smaller particles 
Iron Yes  Size Higher absorption of 
NPs than of bulk 
Selenium Too few data 
to conclude 
 None Not investigated 
Silicium 
dioxide 
Too few data 
to conclude 
 None Not investigated 
Silver Yes up to 100 
nm 
 Size 
 
Polymeric 
coatings/stabil
izers 
Higher absorption of 
smaller particles 
Influence on 
absorption not 
demonstrated 
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Titanium 
dioxide 
Yes  Agglomeration 
 
 
 
Chrystal 
structure 
Agglomeration 
decrease absorption 
of the anatase form 
Rutile form better 
absorbed than the 
anatase form 
Zinc oxide Yes  Size Higher absorption of 
smaller particles 
 
 
3.12 Phase II.2  Identification of most relevant test method(s) for 
systemic absorption of nanomaterials following oral exposure 
General principles on absorption and distribution, metabolism and excretion (ADME) of chemical 
substances are described in OECD test guideline 417 on toxicokinetics.  
ADME studies are essential for the safety evaluation of nanomaterials because the chemical and 
physical characteristics of the nanomaterials may result in substantial different absorption and 
other toxicokinetic parameters than those seen for the non-nanoform of the same material. If there 
is any potential exposure e.g. via the oral route it is recommended by EFSA (EFSA, 2011) to perform 
an ADME study as one of the initial test. However, there may be difficulties in measuring NPs in 
blood, tissues and excreta and to establish the form in which they are present in the body. As 
mentioned in 3.12 Phase II.2 it is important that techniques are available either to detect the 
nanomaterial as particles or as their dissolved components in tissues and excreta. Alternatively, 
labelling may be used either directly, as radioactive isotopes, or indirectly using fluorescent dyes or 
a radiolabel. This is discussed in section 3.12. Analyses by ICP-MS, which have been extensively 
used has the limitation that only the element is determined but not its presence as an NP. However, 
if the method is combined with a suitable separation technique this problem could be overcome. 
Labelling however, has the disadvantage that the label may be released and analytically determined 
separate from the NPs. This situation would obviously lead to erroneous results for absorption and 
distribution of the NPs. In addition, the impact on the label itself on the ADME properties and 
activities of the NPs should be considered.  
There are on-going developments of in vitro methods, but currently there are no in vitro methods 
validated to be used for hazard assessment or absorption of nanomaterials (or other chemicals) 
following oral exposure to NPs.  
Although some in vitro studies related to absorption of nanomaterials after oral exposure have been 
published during recent years, and have been discussed in this report, only very few relevant and 
robust studies have been identified. 
The most relevant model seems to be a model comprising 1) a digestive study (synthetic setup) 
under physiologically relevant conditions combined with 2) an in vitro absorption model 
1) A few digestive studies were identified for Ag-NPs. Walczak et al (Walczak et al. 2012) de-
scribed a model using three consecutive treatments: 1) artificial saliva as medium for Ag-
NPs or AgNO3 as source of Ag-ions. The mixtures were then treated with 2) artificial 
gastric juice, 3) duodenal juice and finally bile juice at 37 oC using mimicked peristaltic 
movements during incubation. In this model it was demonstrated that gastro-intestinal 
digestion has an impact on the Ag-NPs and Ag-ions so that they undergo changes during 
gastro-intestinal digestion. Using this model there is indication that ingestion of both Ag-
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NPs and Ag+ ions ultimately leads to intestinal exposure to NPs, albeit with a different 
chemical composition, such as silver chloride or sulphide.  
A similar in vitro model was used to mimic human digestion of nano-SiO2-NPs in 
different food items. The results from this study (Peters et al. 2012) indicated that the 
intestine is most likely exposed to nanosized SiO2-NPs.   
2) An in vitro model of human follicle epitelium (FAE) was developed and characterized by 
des Rieux and co-workers (des Rieux et al. 2007) for the purpose to study transport of NPs 
by M cells. This method is shortly described in the introduction of this report (section 1.4). 
The model was well characterized by des Rieux et al. (des Rieux et al. 2007). Mono and co-
cultures were analysed by TEM and SEM and the analysis indicated that at least some of 
the Caco-2 cells were converted to M cells. SEM analysis has also been used to identify and 
localize M cells in Payer’s Patch biopsies.  
The percentage of M cells in co-cultures was evaluated to range between 15-30%. This 
information is crucial to interpret results and to compare them with in vivo data. It should 
be noted that the percentage of M cells of the total FAE in the Payer’s Patches is lower in 
rodents (10%) and in humans (< 10%). Therefore, this model may overestimate the 
transport across the intestinal barrier of NPs in humans. However, this inverted co-culture 
model seems to be a useful tool to study the influence of M cells on NP transport. Des 
Rieux and co-workers (des Rieux et al. 2007) validated this model using model NPs (e.g. 
polystyrene model NPs). This model has been used by Bouwmeester et al. (Bouwmeester et 
al. 2011) to study the translocation of Ag-NPs. This study was described in section 3.8.3. 
 
3.13 Phase II.3  Overall conclusion 
In the present report we have evaluated the identified literature on absorption of nanomaterials 
after oral exposure. The identified literature was based on a comprehensive literature search, 
followed by an evaluation of the relevance and reliability of the initially identified papers. This 
resulted in 47 papers, which are discussed in the report and cover the following nanomaterials: 
Carbon nanotubes (CNTs), cerium dioxide (CeO2), fullerenes, gold (Au), iron oxide (Fe2O3), 
selenium, silicium dioxide (SiO2), titanium dioxide (TiO2) and zinc oxide (ZnO). Both in vivo and in 
vitro studies are included as well as a few synthetic set-ups. Although the number of published oral 
exposure studies has increased during the recent years, only very few well performed studies on 
intestinal absorption are available, and more studies are needed to provide a sound science basis for 
risk assessment of exposure of humans to nanoparticles. The conclusions on each of the above 
mentioned nanomaterials are summarized below. 
Carbon nanotubes 
None of the in vivo studies identified in the open literature for this review measured absorption of 
CNTs after oral exposure of laboratory animals in terms of blood and tissue levels. Thus, the 
reviewed in vivo studies neither prove nor rule out any absorption of CNTs from the 
gastrointestinal tract following oral administration. However, the lack of toxicity observed in animal 
treated with oral doses of CNS compared with the toxicity seen in animals after i.v. or i.p. 
administration indirectly indicated either no or very low absorption after oral exposure.  
One of the reviewed in vitro studies reported the presence of agglomerates, which were considered 
by the authors to be non-dispersed carboxylic acid functionalized single walled-CNTs (COOH-
SWCNTs) in Caco-2 cells following the exposure via addition of these nanotubes to the culture 
media as examined by light microscopy. In another study examination by confocal microscopy of 
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erythrocytes exposed to acid functionalized SWCNTs (AF-SWCNTs) suggested that some were 
available to erythrocytes. Whether this only occurred at cytotoxic concentration is not clear. These 
in vitro observations suggest that the CNTs may be able to enter the cells, but do not provide any 
basis to conclude that CNTs can cross the intestinal wall and enter blood circulation. 
Cerium dioxide 
The only in vivo study available measured the organ distribution of Ce after oral administration of 
CeO2-NPs to rats and found low levels in major organs which indicated low absorption. Whether the 
absorption occurred as Ce-ions or as CeO2-NPs, or both, is not shown. The available in vitro study is 
not adequately reported to judge on the potential uptake of CeO2-NPs in human hepatocytes or 
enterocytes. 
Fullerenes 
The only study identified, which compared the distribution of radioactivity after oral and 
intravenous administration of a single dose of 14C labelled water-soluble C60 fullerene indicated very 
limited, if any, absorption after oral exposure. In a toxicity study large oral doses of PVP-coated 
fullerene C60 did not induce toxic effects which could point to a low, or no absorption. However, the 
absorption in terms of blood or liver levels of PVP-fullerene C60 was not measured. The presented 
results did not permit to draw any conclusions concerning oral absorption of PVP-fullerene C60 and 
other fullerenes. 
Gold 
Au-NPs were absorbed at low levels following oral administration by uptake of particulates by 
persorption through holes created by extruding enterocytes from the villi in the small intestine, and 
were distributed to a number of organs in experimental animals. Smaller Au-NPs were absorbed to 
a higher degree than larger ones. 
Iron oxide 
One study investigated the levels of iron in blood and major organs of rats following administration 
by gavage of nano-sized and bulk Fe2O3. It is concluded that iron was more efficiently available to 
organs and tissues from Fe2O3-NPs than from the corresponding bulk material. However, this study 
was not able to clarify whether the iron was absorbed in the form of the nanomaterial or as Fe-ions 
liberated in the gut, or both. In another study it was shown, that metallic iron NPs can be taken up 
by the gastrointestinal mucosa and that the passage of such particles across the epithelia barrier 
may take place through both a paracellular as well as a transcytotic process. 
Selenium 
Only one study was identified. It investigated the transport and uptake of Se from Se-NPs. It was 
concluded that the transport and uptake of Se from Se-NPs were time-dependent and the epithelial 
transport across Caco-2 cell monolayers mainly took place via passive transport pathways. In 
addition, the results strongly indicated that Se-NPs existed as dissolved species in order to make the 
incorporation into the bioactive enzyme possible. The membrane passage of Se dosed as Se-NPs 
was superior to that provided by the two other tested molecular non-nano Se species. 
Silicium dioxide 
Only one in vivo study of limited quality was identified on silicium dioxide, and therefore no firm 
conclusion can be drawn on intestinal absorption of SiO2-NPs. However, in a recent in vitro study it 
was shown that after complete digestion of foods containing SiO2-NPs (E551) a high amount of 
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nano-SiO2-NPs was present in the gut, which may potentially favour the bio-availability of the 
substance. 
Silver 
There is strong evidence that silver from Ag-NPs become absorbed from the GI tract of 
experimental animals. Several studies describe that following oral exposure by gavage silver can be 
detected in the blood and is further distributed to organs. The levels in blood and organs are dose-
dependent and also depends on the size of the Ag-NPs used (i.e. absorption occurs for NPs not 
larger than 100 nm in diameter). Larger particles however seem not to be absorbed to any 
significant extent. Although the reviewed distribution studies were meticulously planned and 
conducted, only few studies touched upon the possible mechanism of the uptake of silver from Ag-
NPs and addressed the question whether the Ag-NPs were absorbed as the pristine NPs or became 
absorbed following dissolution as low-molecular silver species. A few studies however demonstrated 
that silver-containing NPs were detected by electron microscopic (EM) imaging in various animal 
tissues following oral dosage with Ag-NPs but also following dosage of soluble Ag-ions. These 
findings, supported by elemental imaging methods, revealed that the silver NPs co-existed with 
other elements such as selenium and sulphur, or with chloride and sulphur for both forms of silver 
administered via the GI tract. This strongly suggested that Ag-NPs were first dissolved and then re-
deposited as insoluble salts in tissues and organelles. These findings are further supported by 
research in vitro using cell lines or synthetic set-ups, which generally conclude that the trans-
membrane passage or release into synthetic digestive solutions occur equally efficient for Ag-NPs as 
for Ag-ions. This suggests that Ag-NPs can dissolve in the GI tract prior to absorption from the 
small intestine, to enter circulation and subsequently reach primarily the liver and spleen and to a 
lesser degree other organs. A few papers investigated and compared Ag-NPs with different 
polymeric coatings/stabilizers, but were unable to find any difference in their fate in the GI tract or 
in their deposition in the animals’ organs.  
Titanium dioxide 
Although TiO2 is one of the most widely used chemicals in the world, only few studies exist on the 
absorption after oral exposure.   
An in vitro study indicated that TiO2-NPs as such can cross the epithelial lining of the 
gastrointestinal tract at low levels by transcytosis after exposure to concentrations of 10 µg/ml and 
above. 
Three in vivo studies on absorption of the nanoform were identified. For comparison a study on 
absorption of the bulk form is also described in this report. Based on these studies it can be 
concluded that the absorption of TiO2 particles is low and only around 6% for the bulk form. It is 
not possible to estimate the absorbed amount of TiO2-NPs from the available literature, but there is 
some indication that at “near physiological” doses of the anatase form of TiO2-NP (up to 200 mg/kg 
bw/day) no TiO2-NPs could be detected in blood or liver, kidney and spleen (in general the most 
relevant organs for accumulation of NPs). Only at extremely high exposure (5 g/kg bw) 
accumulation was observed in liver, kidneys, spleen and lung. However, it is not possible to evaluate 
the degree of absorption based on this study, and it is also not possible to conclude whether the 
absorbed TiO2 occurred as ions, particles or both. Finally, in most of the evaluated studies, TiO2 
agglomeration was often seen in the suspensions administered to the animals. It therefore remains 
a question to which size distribution of TiO2 the experimental animals were actually exposed. 
Zinc oxide 
The absorption rate of zinc from ZnO-NPs is dose dependent (5-33% depending on the dose), and to 
a lesser extent also size dependent. The absorption was slightly higher for the small particles 
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compared to the larger ones. In most studies zinc was measured and was mainly distributed to liver 
and kidney but was also measured in lung, pancreas and bone in other studies. From one well 
performed study there is strong indications that zinc from ZnO-NPs was distributed to the organs in 
the form of Zn-ions rather than as NPs because Zn-S bonds and not Zn-Zn bonds were observed in 
the tissues where Zn was deposited. ZnO-NPs were mainly excreted via the faeces. Only a minor 
amount of zinc was retained in the analysed organs indicating that zinc and ZnO-NPs did not 
accumulate.  
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4. Phase III: Identification of 
knowledge gaps and 
research needs 
 
Very few in vivo absorption studies have been identified as robust and valid for nanoparticle 
studies. Therefore, studies with an indirect indication of absorption (e.g. distribution to different 
organs), have also been included in the evaluation presented in this report. 
In general more absorption studies are needed on different NPs. In such studies the nanomaterials 
should be well characterized as described by EFSA (EFSA 2011).  
Studies on the influence of physico-chemical characteristics are needed as described in Phase II.1. 
Such studies could initially be performed in the in vitro models described above (Phase II.2), in 
order to save time and animals and get an idea about the mechanisms behind translocation of NPs, 
and the influence of physico-chemical parameters. When more data has been created, it may be 
possible to “read across” or to develop “in situ” models for absorption of “nearly similar” 
nanomaterials.  
Analytical methods for nanomaterial characterisation are under enormous development and 
comprise wet chemical techniques, often based on atomic spectroscopy, and on imaging methods, 
e.g. electron microscopy techniques. There is a need for further development of sensitive and 
reliable methods for the detection, characterization and quantification of NPs especially in 
food/feed and tissues collected from in vivo or in vitro study models. From such studies it is 
important to collect information of whether substances are absorbed as particles, ions or a 
combination of both.  
The state-of-the art of analytical characterisation actually allows for characterisation of especially 
metal-containing intact nanomaterials in food and tissues etc., but relevant data is most likely not 
reported owing to the fact that the investigators do not realise that a nanomaterial can become 
dissolved upon interaction with a biological system.  
In research projects, where the investigators have access to a modern “analytical toolbox”, the 
selective detection of ions vs. NPs of a given nanomaterial can be achieved in a number of ways. In 
general, methodologies which first make use of a separation technique such as field flow 
fractionation or size exclusion chromatography followed by detectors selective to NPs (light 
scattering or UV spectroscopy) or selective to both the dissolved and the nanoparticle state of a 
metallic element (ICP-MS) may be a way to achieve more relevant characterisation information in 
future projects. Finally it should be mentioned that single particle ICP-MS is a particularly 
promising analytical technique as it is not only highly sensitive (physiological relevant 
concentrations), but may also at the same time provide information on dissolved ionic matter and 
number and size of NPs in the same analytical procedure. Such techniques should be further 
investigated in future research on NPs in a biological or environmental context. Furthermore, such 
an analytical technique is well-suited to address the question of the number-based size distribution 
of a metallic NP suspension. 
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In analogy with the selective chemical characterisation of dissolved and nanoparticulate matter, 
emphasis should also be placed on NPs labelled with fluorophors. Because the fluorophor is used as 
a marker for the presence of the NPs to which they were attached, it is crucial that this binding is 
stable. Otherwise, the characterisation work may erroneously provide information on the detached 
label and not on the intact fluorophor-NP assembly.  
4.1 Recommendations on which nanomaterials could be candidates for 
future experimental testing  
Based on the evaluation of different nanomaterials in the present report substances known to have 
a high exposure level via the oral route could be candidates in a potential future project on systemic 
absorption of nanomaterials by oral exposure. Such substances are: silver, SiO2-NPs (E 551), TiO2 
(E 171) and ZnO. Based on current knowledge there is strong indications that silver is absorbed 
partially as ions and therefore the hazard identification and hazard characterization may rely on 
data for the non-nanoform (EFSA 2011). 
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Appendix 1: Literature search 
As the reference research tool SciFinder has been used. SciFinder is a bibliographic and reference 
research tool that provides access to the Main Chemical Abstracts Service (CAS) literature database 
of over 36 million references (CAPLUS) back to 1900. SciFinder also provides access to the entire 
MEDLINE database (1946+), journal tables of contents, and citation linking. In the below reported 
literature search no limitation was made on period. 
Terms used in the following Appendixes: 
Nano: Term used to identify words starting with “nano-“.  
Refine: means to identify and include hits within a number of hits (e.g.: “refine: oral”: gives the hits 
containing the word oral within the group of hits of nano-).    
Exclude: means to identify and exclude hits within a number of hits (e.g.: “exclude patents” will 
exclude all patents from the search).  
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Appendix 2: Available hits based on “nano” and other search terms 
Appendix 2 contains a table with the first search made with the search term “nano” and other with 
various limitations applied to the search. The result revealed that the number of hits was too many 
to process by retrieving relevant papers based on this search.  
To continue a first step was made to identify commonly used terms, not relevant for the purpose of 
this project, starting with “nano-“ – see Appendix 3. 
Date of search: 20/1/2013 
 
SEARCH-
number 
Search terms 
(e.g. substance 
name, CAS No and 
combinations.etc) 
Limitations 
applied to search 
No of 'hits' Comments & 
follow-up 
actions 
SEARCH-1 Nano    1203755   
SEARCH-2 Nano Exclude Patents   1045829   
SEARCH-3 Nano Exclude Patents 
Refine: oral  
 4760   
SEARCH-4 Nano Exclude Patents 
Refine: oral  
Refine: uptake 
 537   
SEARCH-5 Nano Exclude Patents 
Refine: oral  
Refine: absorption 
 777   
SEARCH-6 Nano Exclude Patents 
Refine: gavage 
123   
SEARCH-7 Nano Exclude Patents 
Refine: food 
15430 Includes “feed”  
SEARCH-8 Nano Exclude Patents 
Refine: absorption 
70970  
SEARCH-9 Nano Exclude Patents 
Refine: gastro-
intestinal 
1559  
SEARCH-10 Nano Exclude Patents 
Refine: gi tract 
1041  
SEARCH-11 Nano Exclude Patents 
Refine: digestive 
tract 
1041  
SEARCH-12 Nano Exclude Patents 
Refine: gastric 
60435  
SEARCH-13 Nano Exclude Patents 
Refine: saliva 
641  
SEARCH-14 Nano Exclude Patents 2554  
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SEARCH-
number 
Search terms 
(e.g. substance 
name, CAS No and 
combinations.etc) 
Limitations 
applied to search 
No of 'hits' Comments & 
follow-up 
actions 
Refine: intestine 
SEARCH-15 Nano Exclude Patents 
Refine: stomach 
1101  
SEARCH-16 Nano Exclude Patents 
Refine: duodenum 
117  
SEARCH-17 Nano Exclude Patents 
Refine: jejunum 
114  
SEARCH-18 Nano Exclude Patents 
Refine: ileum 
226  
SEARCH-19 Nano Exclude Patents 
Refine: peyer’s 
patch 
106  
SEARCH-20 Nano Exclude Patents 
Refine: cecum 
65  
SEARCH-21 Nano Exclude Patents 
Refine: colon 
1432  
SEARCH-22 Nano Exclude Patents 
Refine: feces 
389 Includes “faeces” 
SEARCH-23 Nano Exclude Patents 
Refine: epithelial 
barrier 
156  
SEARCH-24 Nano Exclude Patents 
Refine: cell line 
22213  
SEARCH-25 Nano Exclude Patents 
Refine: caco-2 
1367  
SEARCH-26 Nano Exclude Patents 
Refine: enterocyte 
354  
SEARCH-27 Nano Exclude Patents 
Refine: consumer 
products 
1354  
SEARCH-28 Microparticle     50383   
SEARCH-29 Microparticle  Exclude Patents   28666   
SEARCH-30 Microparticle  Exclude Patents 
Refine: oral  
 962   
SEARCH-31 Microparticle  Exclude Patents 
Refine: uptake 
677   
SEARCH-32 Microparticle  Exclude Patents 
Refine: gavage 
20   
SEARCH-33 Microparticle  Exclude Patents 
Refine: food 
621  Includes “feed” 
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SEARCH-
number 
Search terms 
(e.g. substance 
name, CAS No and 
combinations.etc) 
Limitations 
applied to search 
No of 'hits' Comments & 
follow-up 
actions 
SEARCH-34 Microparticle  Exclude Patents 
Refine: absorption 
960   
SEARCH-35 Microparticle  Exclude Patents 
Refine: gastro-
intestinal 
296   
SEARCH-36 Microparticle  Exclude Patents 
Refine: gi tract 
218  Includes 
“digestive tract” 
SEARCH-37 Microparticle  Exclude Patents 
Refine: gastric 
1405  
SEARCH-38 Microparticle  Exclude Patents 
Refine: saliva 
47  
SEARCH-39 Microparticle  Exclude Patents 
Refine: intestine 
518  
SEARCH-40 Microparticle  Exclude Patents 
Refine: stomach 
130  
SEARCH-41 Microparticle  Exclude Patents 
Refine: duodenum 
8  
SEARCH-42 Microparticle  Exclude Patents 
Refine: jejunum 
16  
SEARCH-43 Microparticle  Exclude Patents 
Refine: ileum 
17  
SEARCH-44 Microparticle  Exclude Patents 
Refine: peyer’s 
patch 
101  
SEARCH-45 Microparticle  Exclude Patents 
Refine: cecum 
3  
SEARCH-46 Microparticle  Exclude Patents 
Refine: colon 
134  
SEARCH-47 Microparticle  Exclude Patents 
Refine: feces 
41 Includes “faeces” 
SEARCH-48 Microparticle  Exclude Patents 
Refine: epithelial 
barrier 
31  
SEARCH-49 Microparticle  Exclude Patents 
Refine: cell line 
684  
SEARCH-50 Microparticle  Exclude Patents 
Refine: caco-2 
115  
SEARCH-51 Microparticle  Exclude Patents 
Refine: enterocyte 
30  
SEARCH-52 Microparticle  Exclude Patents 25  
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SEARCH-
number 
Search terms 
(e.g. substance 
name, CAS No and 
combinations.etc) 
Limitations 
applied to search 
No of 'hits' Comments & 
follow-up 
actions 
Refine: consumer 
product 
SEARCH-53  Particle   2035968   
SEARCH-54  Particle  Exclude Patents 1569025   
SEARCH-55  Particle  Exclude Patents 
Refine: oral 
10051   
SEARCH-56  Particle  Exclude Patents 
Refine: uptake 
25407   
SEARCH-57  Particle  Exclude Patents 
Refine: gavage 
181   
SEARCH-58  Particle  Exclude Patents 
Refine: food 
35903 Includes “feed”  
SEARCH-59  Particle  Exclude Patents 
Refine: absorption 
64704   
SEARCH-60  Particle  Exclude Patents 
Refine: gastro-
intestinal 
3932   
SEARCH-61  Particle  Exclude Patents 
Refine: gi tract 
2622  Includes 
“digestive tract”  
SEARCH-62  Particle  Exclude Patents 
Refine: gastric 
152641   
SEARCH-63  Particle  Exclude Patents 
Refine: saliva 
1332   
SEARCH-64  Particle  Exclude Patents 
Refine: intestine 
6213   
SEARCH-65  Particle  Exclude Patents 
Refine: stomach 
2383   
SEARCH-66  Particle  Exclude Patents 
Refine: duodenum 
473   
SEARCH-67  Particle  Exclude Patents 
Refine: jejunum 
360   
SEARCH-68  Particle  Exclude Patents 
Refine: ileum 
369   
SEARCH-69  Particle  Exclude Patents 
Refine: peyer’s 
patch 
289   
SEARCH-70  Particle  Exclude Patents 
Refine: cecum 
202   
SEARCH-71  Particle  Exclude Patents 
Refine: colon 
1659   
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SEARCH-
number 
Search terms 
(e.g. substance 
name, CAS No and 
combinations.etc) 
Limitations 
applied to search 
No of 'hits' Comments & 
follow-up 
actions 
SEARCH-72  Particle  Exclude Patents 
Refine: feces 
2630 Includes “faeces”  
SEARCH-73  Particle  Exclude Patents 
Refine: epithelial 
barrier 
258   
SEARCH-74  Particle  Exclude Patents 
Refine: cell line 
28248   
SEARCH-75  Particle  Exclude Patents 
Refine: caco-2 
2249   
SEARCH-76  Particle  Exclude Patents 
Refine: enterocyte 
701   
SEARCH-77  Particle  Exclude Patents 
Refine: consumer 
product 
2207   
SEARCH-78  Particulate   
 
197692   
SEARCH-79  Particulate  Exclude Patents 
 
155207   
SEARCH-80 Particulate  Exclude Patents 
Refine: oral 
727   
SEARCH-81 Particulate  Exclude Patents 
Refine: uptake 
3871   
SEARCH-82 Particulate  Exclude Patents 
Refine: gavage 
26   
SEARCH-83 Particulate  Exclude Patents 
Refine: food 
5164 Includes “feed”  
SEARCH-84 Particulate  Exclude Patents 
Refine: absorption 
5285   
SEARCH-85 Particulate  Exclude Patents 
Refine: gastro-
intestinal 
724   
SEARCH-86 Particulate  Exclude Patents 
Refine: gi tract 
459  Includes 
“digestive tract”  
SEARCH-87  Particulate  Exclude Patents 
Refine: gastric 
32440   
SEARCH-88 Particulate  Exclude Patents 
Refine: saliva 
229   
SEARCH-89 Particulate  Exclude Patents 
Refine: intestine 
1084   
SEARCH-90 Particulate  Exclude Patents 384   
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SEARCH-
number 
Search terms 
(e.g. substance 
name, CAS No and 
combinations.etc) 
Limitations 
applied to search 
No of 'hits' Comments & 
follow-up 
actions 
Refine: stomach 
SEARCH-91 Particulate  Exclude Patents 
Refine: duodenum 
121   
SEARCH-92 Particulate  Exclude Patents 
Refine: jejunum 
72   
SEARCH-93 Particulate  Exclude Patents 
Refine: ileum 
110   
SEARCH-94 Particulate  Exclude Patents 
Refine: peyer’s 
patch 
82   
SEARCH-95 Particulate  Exclude Patents 
Refine: cecum 
48   
SEARCH-96 Particulate  Exclude Patents 
Refine: colon 
263   
SEARCH-97 Particulate  Exclude Patents 
Refine: feces 
652 Includes “faeces”  
SEARCH-98 Particulate  Exclude Patents 
Refine: epithelial 
barrier 
65   
SEARCH-99 Particulate  Exclude Patents 
Refine: cell line 
2117   
SEARCH-
100 
Particulate  Exclude Patents 
Refine: caco-2 
183   
SEARCH-101 Particulate  Exclude Patents 
Refine: enterocyte 
134   
SEARCH-
102 
Particulate  Exclude Patents 
Refine: consumer 
product 
640   
SEARCH-
103 
Colloid   
 
276502   
SEARCH-
104 
Colloid  Exclude Patents 204649   
SEARCH-
105 
Colloid  Exclude Patents 
Refine: oral 
1523   
SEARCH-
106 
Colloid  Exclude Patents 
Refine: uptake 
3440   
SEARCH-
107 
Colloid  Exclude Patents 
Refine: gavage 
37   
SEARCH-
108 
Colloid  Exclude Patents 
Refine: food 
4373 Includes “feed”  
78 Systemic Absorption of Nanomaterials by Oral Exposure 
 
SEARCH-
number 
Search terms 
(e.g. substance 
name, CAS No and 
combinations.etc) 
Limitations 
applied to search 
No of 'hits' Comments & 
follow-up 
actions 
SEARCH-
109 
Colloid  Exclude Patents 
Refine: absorption 
12361   
SEARCH-110 Colloid  Exclude Patents 
Refine: gastro-
intestinal 
1149   
SEARCH-111 Colloid  Exclude Patents 
Refine: gi tract 
494  Includes 
“digestive tract”  
SEARCH-112 Colloid  Exclude Patents 
Refine: gastric 
8258   
SEARCH-113 Colloid  Exclude Patents 
Refine: saliva 
326   
SEARCH-114 Colloid  Exclude Patents 
Refine: intestine 
1486   
SEARCH-115 Colloid  Exclude Patents 
Refine: stomach 
951   
SEARCH-116 Colloid  Exclude Patents 
Refine: duodenum 
149   
SEARCH-117 Colloid  Exclude Patents 
Refine: jejunum 
86   
SEARCH-118 Colloid  Exclude Patents 
Refine: ileum 
80   
SEARCH-119 Colloid  Exclude Patents 
Refine: peyer’s 
patch 
27   
SEARCH-
120 
Colloid  Exclude Patents 
Refine: cecum 
69   
SEARCH-121 Colloid  Exclude Patents 
Refine: colon 
440   
SEARCH-
122 
Colloid  Exclude Patents 
Refine: feces 
294 Includes “faeces”  
SEARCH-
123 
Colloid  Exclude Patents 
Refine: epithelial 
barrier 
36   
SEARCH-
124 
Colloid  Exclude Patents 
Refine: cell line 
1383   
SEARCH-125 Colloid  Exclude Patents 
Refine: caco-2 
348   
SEARCH-
126 
Colloid  Exclude Patents 
Refine: enterocyte 
101   
SEARCH-127 Colloid  Exclude Patents 264   
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SEARCH-
number 
Search terms 
(e.g. substance 
name, CAS No and 
combinations.etc) 
Limitations 
applied to search 
No of 'hits' Comments & 
follow-up 
actions 
Refine: consumer 
product 
SEARCH-
128 
Quantum dot  68889   
SEARCH-
129 
Quantum dot Exclude Patents 63329   
SEARCH-
130 
Quantum dot Exclude Patents 
Refine: oral 
45   
SEARCH-131 Quantum dot Exclude Patents 
Refine: uptake 
560   
SEARCH-
132 
Quantum dot Exclude Patents 
Refine: gavage 
0   
SEARCH-
133 
Quantum dot Exclude Patents 
Refine: food 
240 Includes “feed”  
SEARCH-
134 
Quantum dot Exclude Patents 
Refine: absorption 
6110   
SEARCH-135 Quantum dot Exclude Patents 
Refine: gastro-
intestinal 
35   
SEARCH-
136 
Quantum dot Exclude Patents 
Refine: gi tract 
23  Includes 
“digestive tract”  
SEARCH-137 Quantum dot Exclude Patents 
Refine: gastric 
2126   
SEARCH-
138 
Quantum dot Exclude Patents 
Refine: saliva 
12   
SEARCH-
139 
Quantum dot Exclude Patents 
Refine: intestine 
47   
SEARCH-
140 
Quantum dot Exclude Patents 
Refine: stomach 
35   
SEARCH-141 Quantum dot Exclude Patents 
Refine: duodenum 
3   
SEARCH-
142 
Quantum dot Exclude Patents 
Refine: jejunum 
1   
SEARCH-
143 
Quantum dot Exclude Patents 
Refine: ileum 
2   
SEARCH-
144 
Quantum dot Exclude Patents 
Refine: peyer’s 
patch 
2   
SEARCH-
145 
Quantum dot Exclude Patents 
Refine: cecum 
0   
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SEARCH-
number 
Search terms 
(e.g. substance 
name, CAS No and 
combinations.etc) 
Limitations 
applied to search 
No of 'hits' Comments & 
follow-up 
actions 
SEARCH-
146 
Quantum dot Exclude Patents 
Refine: colon 
51   
SEARCH-147 Quantum dot Exclude Patents 
Refine: feces 
24 Includes “faeces”  
SEARCH-
148 
Quantum dot Exclude Patents 
Refine: epithelial 
barrier 
7   
SEARCH-
149 
Quantum dot Exclude Patents 
Refine: cell line 
1028   
SEARCH-
150 
Quantum dot Exclude Patents 
Refine: caco-2 
14   
SEARCH-151 Quantum dot Exclude Patents 
Refine: enterocyte 
5   
SEARCH-152 Quantum dot Exclude Patents 
Refine: consumer 
product 
31   
SEARCH-153 Fullerene  58538   
SEARCH-
154 
Fullerene Exclude Patents 52673   
SEARCH-155 Fullerene Exclude Patents 
Refine: oral 
26   
SEARCH-
156 
Fullerene Exclude Patents 
Refine: uptake 
225   
SEARCH-157 Fullerene Exclude Patents 
Refine: gavage 
2   
SEARCH-
158 
Fullerene Exclude Patents 
Refine: food 
157 Includes “feed”  
SEARCH-
159 
Fullerene Exclude Patents 
Refine: absorption 
5485   
SEARCH-
160 
Fullerene Exclude Patents 
Refine: gastro-
intestinal 
21   
SEARCH-161 Fullerene Exclude Patents 
Refine: gi tract 
16  Includes 
“digestive tract”  
SEARCH-
162 
Fullerene Exclude Patents 
Refine: gastric 
2694   
SEARCH-
163 
Fullerene Exclude Patents 
Refine: saliva 
3   
SEARCH-
164 
Fullerene Exclude Patents 
Refine: intestine 
25   
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SEARCH-
number 
Search terms 
(e.g. substance 
name, CAS No and 
combinations.etc) 
Limitations 
applied to search 
No of 'hits' Comments & 
follow-up 
actions 
SEARCH-
165 
Fullerene Exclude Patents 
Refine: stomach 
11   
SEARCH-
166 
Fullerene Exclude Patents 
Refine: duodenum 
0   
SEARCH-167 Fullerene Exclude Patents 
Refine: jejunum 
2   
SEARCH-
168 
Fullerene Exclude Patents 
Refine: ileum 
2   
SEARCH-
169 
Fullerene Exclude Patents 
Refine: peyer’s 
patch 
0   
SEARCH-
170 
Fullerene Exclude Patents 
Refine: cecum 
0   
SEARCH-171 Fullerene Exclude Patents 
Refine: colon 
8   
SEARCH-172 Fullerene Exclude Patents 
Refine: feces 
8 Includes “faeces”  
SEARCH-173 Fullerene Exclude Patents 
Refine: epithelial 
barrier 
3   
SEARCH-174 Fullerene Exclude Patents 
Refine: cell line 
210   
SEARCH-175 Fullerene Exclude Patents 
Refine: caco-2 
3   
SEARCH-176 Fullerene Exclude Patents 
Refine: enterocyte 
4   
SEARCH-177 Fullerene Exclude Patents 
Refine: consumer 
product 
54   
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Appendix 3: List of non-relevant “nano-terms” 
Appendix 3 contains a table showing the results of a step in the literature search made to identify 
commonly used terms, not relevant for the purpose of this project, starting with “nano-“. This was 
done to see if exclusion of these search terms could diminish the number of hits.  
Two approaches were used: first approach identified the number of hits containing the commonly 
used terms. Second approach identified the number of hits containing nano* but not commonly 
used terms deemed not relevant. 
Date of search: 23/1/2013 
SEARCH-
number 
Search term Number 
of hits 
Comments 
SEARCH-
178 
Nano* 1205965 1205965 references were found 
containing the concept* "nano" (i.e. 
all words containing “nano” were 
identified in this search) 
SEARCH-
179 
Nano 172260 172260 references were found 
containing "nano" as entered 
SEARCH-
180 
Nanogram 8055 8055 references were found 
containing the concept "nanogram"  
SEARCH-
181 
Nanosecond 24432 24432 references were found 
containing the concept 
"nanosecond" 
SEARCH-
182 
Nanomet* (meter, 
metres, metre etc) 
79032 79032 references were found 
containing the concept "nanomet" 
    
SEARCH-
183 
Nano* 1205965  
SEARCH-
184 
Refine: NOT 
nanogram 
1197910 The number of hits for nano* 
excluding all hits containing 
nanogram 
SEARCH-
185 
Refine: NOT 
nanosecond 
1173478 The number of hits for nano* 
excluding all hits containing 
nanosecond 
SEARCH-
186 
Refine: NOT 
nanometer 
1094819 The number of hits for nano* 
excluding all hits containing 
nanometer 
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Appendix 4: First screening for relevant original papers 
Appendix 4 contains a table showing the results of literature searches based on decisions made by 
the chemistry and toxicology experts that the following combination shown in the table should be 
applied. Reviews were excluded as it was suggested that a search could be made at a later stage on 
specifically on reviews. 
25/1/2013: Search performed for original papers considered relevant for this evaluation with the 
number of hits shown. 
30/1/2013: Search performed for original papers considered relevant for this evaluation and further 
refined by excluding terms considered not relevant for the purpose of this project. 
Date of search: 25 & 30/1/2013 
SEARCH-
number 
Search terms 
(e.g. substance 
name, CAS No 
and combinations 
etc) 
Limitations applied 
to search 
No of 
'hits' 
25/1 
No of 
'hits' 
30/1 
Comments & 
follow-up 
actions 
SEARCH-
187 
Nano   1207566 945516* *All reports in 
Chinese have 
been excluded 
as have reviews 
and patents 
before search 
on Nano was 
initiated  
SEARCH-
188 
Nano Refine: oral  9058 6444  
SEARCH-
189 
Nano Refine: oral  
Exclude Patents and 
review 
 
6866 --*  
SEARCH-
190 
Nano Refine: oral  
Exclude Patents and 
review 
Refine: uptake 
732 723  
SEARCH-
191 
Nano Refine: oral  
Exclude Patents and 
review 
Refine: uptake Refine: 
absorption 
280 276  
SEARCH-
192 
Nano Refine: oral  
Exclude Patents and 
review 
Refine: uptake Refine: 
absorption  
excluding “nanogram” 
277 273  
SEARCH-
193 
Nano Refine: oral  
Exclude Patents and 
275 271  
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SEARCH-
number 
Search terms 
(e.g. substance 
name, CAS No 
and combinations 
etc) 
Limitations applied 
to search 
No of 
'hits' 
25/1 
No of 
'hits' 
30/1 
Comments & 
follow-up 
actions 
review 
Refine: uptake Refine: 
absorption  
excluding “nanogram”  
excluding “dermal” 
SEARCH-
194 
Nano Refine: oral  
Exclude Patents and 
review 
Refine: uptake Refine: 
absorption  
excluding “nanogram”  
excluding “dermal”  
excluding “inhalation” 
269 266  
SEARCH-
195 
Nano Refine: oral  
Exclude Patents and 
review 
Refine: uptake Refine: 
absorption  
excluding “nanogram”  
excluding “dermal”  
excluding “inhalation”  
excluding duplicates of 
papers 
226 223 25/1  
Abstracts in 
pdf:  
Nano uptake 
abs 250113  
SEARCH-
196 
Nano Refine: oral  
Exclude Patents and 
review 
Refine: uptake Refine: 
absorption  
excluding “nanogram”  
excluding “dermal”  
excluding “inhalation”  
excluding duplicates of 
papers  
excluding “drug” 
 14  
SEARCH-
197 
Nano Refine: oral  
Exclude Patents and 
review 
Refine: uptake Refine: 
absorption  
excluding “nanogram”  
excluding “dermal”  
excluding “inhalation”  
excluding duplicates of 
papers  
excluding “drug”  
excluding “insulin” 
 12  
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SEARCH-
number 
Search terms 
(e.g. substance 
name, CAS No 
and combinations 
etc) 
Limitations applied 
to search 
No of 
'hits' 
25/1 
No of 
'hits' 
30/1 
Comments & 
follow-up 
actions 
SEARCH-
198 
Nano Refine: oral  
Exclude Patents and 
review 
Refine: uptake Refine: 
absorption  
excluding “nanogram”  
excluding “dermal”  
excluding “inhalation”  
excluding duplicates of 
papers  
excluding “drug”  
excluding “insulin”  
excluding “nanomolar” 
 12  
SEARCH-
199 
Nano Refine: oral  
Exclude Patents and 
review 
Refine: uptake Refine: 
absorption  
excluding “nanogram”  
excluding “dermal”  
excluding “inhalation”  
excluding duplicates of 
papers  
excluding “drug”  
excluding “insulin”  
excluding “nanomolar”  
excluding 
“nanoemulsion” 
 12 30/1 
Abstracts in 
pdf:  
Nano uptake 
abs 300113  
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Appendix 5: Second screening for relevant original papers 
Appendix 5 contains a table showing the results of literature searches based on decisions made on 
the previous results with the exception that reviews were included in the below search, however, 
they have not been scrutinised at this stage. 
It was concluded that the search should exclude the following terms: drug, insulin, cancer, delivery, 
nanomolar, nanoemulsion, nanogram, [language: Chinese], patent – and the search was 
subsequently refined with each of the following terms: Oral, Oral + Absorption, Oral + Uptake, 
Gavage, Gavage not oral, Gavage + Absorption, Gavage + Uptake, Gastro-intestinal, Gastro-
intestinal not oral, Gastro-intestinal not oral and not uptake, Caco-2 + Uptake. 
Abstracts of the relevant results were printed out and chemistry and toxicology experts went 
through the abstracts. See Appendix 5 for a list of these relevant results.    
.Ris files were saved for import to the Reference Manager database. 
Date for search: 3/2/2013 
SEARCH-
number 
Search terms  
(e.g. substance 
name, CAS No and 
combinations.etc) 
Limitations 
applied to 
search 
No of 
'hits' 
List of 
relevant 
items  
Comments 
& follow-up 
actions 
SEARCH-
200 
Nano Exclude patents 
and language 
Chinese 
965715   
SEARCH-
201 
Nano Exclude patents 
and language 
Chinese 
excluding “drug” 
882784   
SEARCH-
202 
Nano Exclude patents 
and language 
Chinese 
excluding “drug” 
excluding “insulin” 
881248   
SEARCH-
203 
Nano Exclude patents 
and language 
Chinese 
excluding “drug” 
excluding “insulin” 
excluding “cancer” 
865907   
SEARCH-
204 
Nano Exclude patents 
and language 
Chinese 
excluding “drug” 
excluding “insulin” 
excluding “cancer” 
excluding 
“delivery” 
856567   
SEARCH-
205 
Nano Exclude patents 
and language 
Chinese 
843101   
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SEARCH-
number 
Search terms  
(e.g. substance 
name, CAS No and 
combinations.etc) 
Limitations 
applied to 
search 
No of 
'hits' 
List of 
relevant 
items  
Comments 
& follow-up 
actions 
 excluding “drug” 
excluding “insulin” 
excluding “cancer” 
excluding 
“delivery” 
excluding 
“nanomolar” 
SEARCH-
206 
Nano Exclude patents 
and language 
Chinese 
 excluding “drug” 
excluding “insulin” 
excluding “cancer” 
excluding 
“delivery” 
excluding 
“nanomolar” 
excluding 
“nanoemulsion” 
842472   
SEARCH-
207 
Nano Exclude patents 
and language 
Chinese 
 excluding “drug” 
excluding “insulin” 
excluding “cancer” 
excluding 
“delivery” 
excluding 
“nanomolar” 
excluding 
“nanoemulsion” 
excluding 
“nanogram” 
836397  The following 
limitations are 
applied to this 
figure 
Doublets are 
automatically 
removed  
SEARCH-
208 
Nano The search result 
(836397 hits)  
Refine: “Oral” 
685   
SEARCH-
209 
Nano The above search 
result (685) 
Refine: “oral” + 
“absorption” 
44  Hits saved as 
.ris and .pdf 
(abstracts) 
SEARCH-
210 
Nano The above search 
result (685) 
Refine:  
“oral” + “uptake” 
26  Hits saved as 
.ris and .pdf 
(abstracts) 
SEARCH-
211 
Nano The search result 
(836397 hits) 
43   
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SEARCH-
number 
Search terms  
(e.g. substance 
name, CAS No and 
combinations.etc) 
Limitations 
applied to 
search 
No of 
'hits' 
List of 
relevant 
items  
Comments 
& follow-up 
actions 
Refine:   
“Gavage” 
SEARCH-
212 
Nano The above search 
result (43) 
excluding “Oral” 
15  Hits saved as 
.ris and .pdf 
(abstracts) 
SEARCH-
213 
Nano The above search 
result (15) 
Refine: 
“Absorption” 
1 Not 
relevant – 
concerns 
NaNO2 
 
SEARCH-
214 
Nano The above search 
result (15) 
Refine  
“Uptake” 
1  Hits saved as 
.ris and .pdf 
(abstracts) 
SEARCH-
215 
Nano The search result 
(836397 hits) 
Refine: “Gastro-
intestinal” 
447   
SEARCH-
216 
Nano The above search 
result (447) 
excluding “oral” 
403   
SEARCH-
217 
Nano The above search 
result (403) 
excluding “uptake”  
401  Hits saved as 
.ris and .pdf 
(abstracts) 
SEARCH-
218 
Nano The search result 
(836397 hits) 
 Refine “Caco-2”  
486   
SEARCH-
219 
Nano The above search 
result (486) Refine  
“Caco-2” + 
“uptake” 
33  Hits saved as 
.ris and .pdf 
(abstracts) 
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Appendix 6: List of abstracts from second screening 
Appendix 6 contains a list of abstracts based on the literature search described in Appendix 5. 
A rough sorting based on the abstracts in these lists was made by at least one toxicologist and one 
chemist. Possible relevant papers were marked and included in a Reference Manager database and 
the original papers obtained. The Reference Manager database contains one database with original 
papers.  
SEARCH-
number 
name of the .pdf containing the result of 
limitation applied to the search 
number of 
abstracts in 
the .pdf 
SEARCH-209 Nano_oral-abs_030213 44 
SEARCH-210 Nano_oral_uptake_030213 26 
SEARCH-212 Nano_gavage_not oral_030213 15 
SEARCH-217 Nano_gastro_not oral uptake_030213 401 
SEARCH-219 Nano_caco2_uptake_030213 33 
 Total 519 
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Appendix 7:  List of all references included in the Reference Manager 
database  
 
Abe, S., Koyama, C., Esaki, M., Akasaka, T., Uo, M., Kuboki, Y., Morita, M., & Watari, F. 2009. In vivo internal 
diffusion of several inorganic microparticles through oral administration. Biomedical Materials and 
Engineering, 19, (2-3) 221-229 
Asuri, P., Karajanagi, S.S., Vertegel, A.A., Dordick, J.S., & Kane, R.S. 2007. Enhanced stability of enzymes 
adsorbed onto nanoparticles. Journal of Nanoscience and Nanotechnology, 7, (4/5) 1675-1678 
Awasthi, K.K., John, P.J., Awasthi, A., & Awasthi, K. 2013. Multi walled carbon nano tubes induced 
hepatotoxicity in Swiss albino mice.  Micron, 44, 359-364 
Baek, M., Chung, H.E., Yu, J., Lee, J.A., Kim, T.H., Oh, J.M., Lee, W.J., Paek, S.M., Lee, J.K., Jeong, J., Choy, 
J.H., & Choi, S.J. 2012. Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles. 
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 Systemic Absorption of Nanomaterials by Oral Exposure 
This report and accompanying database systematically evaluates the reliability and relevance of the 
existing scientific literature regarding systemic absorption of nanomaterials by oral exposure and makes 
specific recommendations for future testing approaches. 
 
Rapporten og den tilhørende database gennemgår systematisk pålideligheden og relevansen af den 
eksisterende videnskabelige litteratur vedrørende optag af nanomaterialer over mavetarmkanalen og 
kommer med konkrete anbefalinger til fremtidige testmetoder. 
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